Abstract
The purpose of this expert review is to discuss the impact of nanotechnology in the treatment of the major health threats including cancer, infections, metabolic diseases, autoimmune diseases, and inflammations. Indeed, during the past 30 years, the explosive growth of nanotechnology has burst into challenging innovations in pharmacology, the main input being the ability to perform temporal and spatial site-specific delivery. This has led to some marketed compounds through the last decade. Although the introduction of nanotechnology obviously permitted to step over numerous milestones toward the development of the “magic bullet” proposed a century ago by the immunologist Paul Ehrlich, there are, however, unresolved delivery problems to be still addressed. These scientific and technological locks are discussed along this review together with an analysis of the current situation concerning the industrial development.
Similar content being viewed by others
References
G. Gregoriadis E. J. Wills C. P. Swain A. S. Tavill (1974) ArticleTitleDrug carrier potential of liposomes in cancer chemotherapy Lancet 1 1313–1316 Occurrence Handle4134296 Occurrence Handle1:STN:280:DyaE2c3lt12lsg%3D%3D Occurrence Handle10.1016/S0140-6736(74)90682-5
C. Hu D. G. Rhodes (2000) ArticleTitleProniosomes: a novel drug carrier preparation Int. J. Pharm. 206 110–122 Occurrence Handle11202988 Occurrence Handle1:STN:280:DC%2BD3M%2FjtVKqsA%3D%3D Occurrence Handle10.1016/S0378-5173(00)00513-5
K. K. Jain (2005) ArticleTitleThe role of nanobiotechnology in drug discovery Drug Discov. Today 10 1435–1442 Occurrence Handle16243263 Occurrence Handle1:CAS:528:DC%2BD2MXhtFers7rL Occurrence Handle10.1016/S1359-6446(05)03573-7
J. K. Vasir M. K. Maram V. D. Labhasetwar (2005) ArticleTitleNanosystems in drug targeting: opportunities and challenges Curr. Nanosci. 1 47–67 Occurrence Handle1:CAS:528:DC%2BD2MXit1aktb4%3D Occurrence Handle10.2174/1573413052953110
A. Bianco J. Hoebeke S. Godefroy O. Chaloin D. Pantarotto J. P. Briand S. Muller M. Prati C. D. Partidos (2005) ArticleTitleCationic carbon nanotubes bind to CpG oligodeoxynucleotides and enhance their immunostimulatory properties J. Am. Chem. Soc. 127 58–59 Occurrence Handle15631447 Occurrence Handle1:CAS:528:DC%2BD2cXhtVyltrvO Occurrence Handle10.1021/ja044293y
A. Bianco K. Costarelos M. Prato (2005) ArticleTitleApplications of carbon nanotubes in drug delivery Curr. Opin. Chem. Biol. 9 674–679 Occurrence Handle16233988 Occurrence Handle1:CAS:528:DC%2BD2MXht1aqu7fJ Occurrence Handle10.1016/j.cbpa.2005.10.005
N. Venkatesan J. Yoshimitsu Y. Ito N. Shibata K. Takada (2005) ArticleTitleLiquid filled nanoparticles as a drug delivery tool for protein therapeutics Biomaterials 26 7154–7163 Occurrence Handle15967493 Occurrence Handle1:CAS:528:DC%2BD2MXmvFCqu7o%3D Occurrence Handle10.1016/j.biomaterials.2005.05.012
M. J. Alonso (2004) ArticleTitleNanomedicine for overcoming biological barriers Biomed. Pharmacother. 58 168–172 Occurrence Handle15082339 Occurrence Handle10.1016/j.biopha.2004.01.007 Occurrence Handle1:CAS:528:DC%2BD2cXjtV2gsLs%3D
R. Sykes (2000) ArticleTitleTowards the magic bullet Int. J. Antimicrob. Agents 14 1–12 Occurrence Handle10717495 Occurrence Handle1:CAS:528:DC%2BD3cXhslelu74%3D Occurrence Handle10.1016/S0924-8579(99)00141-7
R. H. Muller C. Jacobs O. Kayser (2001) ArticleTitleNanosuspensions as particulate drug formulations in therapy rational for development and what we can expect for the future Adv. Drug Deliv. Rev. 47 3–19 Occurrence Handle11251242 Occurrence Handle1:CAS:528:DC%2BD3MXhvVajsr0%3D Occurrence Handle10.1016/S0169-409X(00)00118-6
P. L. Felgner T. R. Gadek M. Holm R. Roman H. W. Chan M. Wenz J. P. Northrop G. M. Ringold M. Danielsen (1987) ArticleTitleLipofection: a highly efficient, lipid-mediated DNA-transfection procedure Proc. Natl. Acad. Sci. USA 84 7413–7417 Occurrence Handle2823261 Occurrence Handle1:CAS:528:DyaL1cXjtlSgug%3D%3D Occurrence Handle10.1073/pnas.84.21.7413
J. P. Behr B. Demeneix J. P. Loeffler J. Perez-Mutul (1989) ArticleTitleEfficient gene transfer into mammalian primary endocrine cells with lipopolyamine-coated DNA Proc. Natl. Acad. Sci. USA 86 6982–6986 Occurrence Handle2780554 Occurrence Handle1:CAS:528:DyaK3cXhvF2l Occurrence Handle10.1073/pnas.86.18.6982
A. M. Krieg (2001) ArticleTitleImmune effects and mechanisms of action of CpG motifs Vaccines 19 618–622 Occurrence Handle10.1016/S0264-410X(00)00249-8
A. M. Krieg (2003) ArticleTitleCpG motifs: the active ingredient in bacterial extracts? Nat. Med. 9 831–835 Occurrence Handle12835699 Occurrence Handle1:CAS:528:DC%2BD3sXkvFKqtbk%3D Occurrence Handle10.1038/nm0703-831
L. Wang R. K. Prekash C. A. Stein K. K. Koehn D. E. Ruffner (2003) ArticleTitleProgress in the delivery of therapeutic oligonucleotides: organ/cellular distribution and targeted delivery of oligonucleotides in vivo Antisense Nucleic Acid Drug Dev. 13 169–189 Occurrence Handle12954117 Occurrence Handle1:CAS:528:DC%2BD3sXmvVOmsro%3D Occurrence Handle10.1089/108729003768247637
T. Hügle A. Cerny (2003) ArticleTitleCurrent therapy and new molecular approaches to antiviral treatment and prevention of hepatitis Crit. Rev. Med. Virol. 13 361–371 Occurrence Handle10.1002/rmv.397 Occurrence Handle1:CAS:528:DC%2BD3sXpslGgtb4%3D
Z. Cui (2005) ArticleTitleDNA vaccine Adv. Genet. 54 257–289 Occurrence Handle16096015 Occurrence Handle1:CAS:528:DC%2BD1cXivFWrt7c%3D
R. K. Jain (1987) ArticleTitleTransport of molecules in the tumor interstitium: a review Cancer Res. 47 3039–3051 Occurrence Handle3555767 Occurrence Handle1:CAS:528:DyaL2sXksFKlu7Y%3D
R. K. Jain (2001) ArticleTitleDelivery of molecular medicine to solid tumors: lessons from in vivo imaging of gene expression and function J. Control. Release 74 7–25 Occurrence Handle11489479 Occurrence Handle1:CAS:528:DC%2BD3MXlslagu7c%3D Occurrence Handle10.1016/S0168-3659(01)00306-6
M. Links R. Brown (1999) ArticleTitleClinical relevance of the molecular mechanisms of resistance to anti-cancer drugs Expert Rev. Mol. Med. 1999 1–21 Occurrence Handle14585120 Occurrence Handle1:STN:280:DC%2BD3srgvFahuw%3D%3D
R. Krishna L. D. Mayer (2000) ArticleTitleMultidrug resistance (MDR) in cancer. Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs Eur. J. Pharm. Sci. 11 265–283 Occurrence Handle11033070 Occurrence Handle1:CAS:528:DC%2BD3cXntF2gtLw%3D Occurrence Handle10.1016/S0928-0987(00)00114-7
I. Brigger C. Dubernet P. Couvreur (2002) ArticleTitleNanoparticles in cancer therapy and diagnosis Adv. Drug Deliv. Rev. 54 631–651 Occurrence Handle12204596 Occurrence Handle1:CAS:528:DC%2BD38XmsVeqtrs%3D Occurrence Handle10.1016/S0169-409X(02)00044-3
J. Kreuter U. Tauber V. Illi (1979) ArticleTitleDistribution and elimination of poly(methyl-2-14C-methacrylate) nanoparticle radioactivity after injection in rats and mice J. Pharm. Sci. 68 1443–1447 Occurrence Handle512896 Occurrence Handle1:CAS:528:DyaL3cXjtlOgsg%3D%3D
J. L. Keyser ParticleDe J. H. Poupaert P. Dumont (1991) ArticleTitlePoly(diethyl methylidenemalonate) nanoparticles as a potential drug carrier: preparation, distribution and elimination after intravenous and peroral administration to mice J. Pharm. Sci. 80 67–70 Occurrence Handle2013853
B. A. Conley M. J. Egorin M. Y. Whitacre D. C. Carter E. C. Zuhowski D. A. Echo ParticleVan (1993) ArticleTitlePhase I and pharmacokinetic trial of liposome-encapsulated doxorubicin Cancer Chemother. Pharmacol. 33 107–112 Occurrence Handle8261569 Occurrence Handle1:STN:280:DyaK2c%2FosVymtg%3D%3D Occurrence Handle10.1007/BF00685327
N. Chiannilkulchai N. Ammoury B. Caillou J. P. Devissaguet P. Couvreur (1990) ArticleTitleHepatic tissue distribution of doxorubicin-loaded nanoparticles after i.v. administration in reticulosarcoma M 5076 metastasis-bearing mice Cancer Chemother. Pharmacol. 26 122–126 Occurrence Handle2189589 Occurrence Handle1:CAS:528:DyaK3cXlsFymsbo%3D Occurrence Handle10.1007/BF02897257
A. C. Verdière Particlede C. Dubernet F. Nemati E. Soma M. Appel J. Ferte S. Bernard F. Puisieux P. Couvreur (1997) ArticleTitleReversion of multidrug resistance with polyalkylcyanoacrylate nanoparticles: towards a mechanism of action Br. J. Cancer 76 198–205 Occurrence Handle9231919
C. E. Soma C. Dubernet G. Barratt F. Nemati M. Appel S. Benita P. Couvreur (1999) ArticleTitleAbility of doxorubicin-loaded nanoparticles to overcome multidrug resistance of tumor cells after their capture by macrophages Pharm. Res. 16 1710–1716 Occurrence Handle10571276 Occurrence Handle1:CAS:528:DyaK1MXnt1Ggs7Y%3D Occurrence Handle10.1023/A:1018902031370
H. B. El-Serag A. C. Mason (1999) ArticleTitleRising incidence of hepatocellular carcinoma in the United States N. Engl. J. Med. 340 745–750 Occurrence Handle10072408 Occurrence Handle1:STN:280:DyaK1M7ls1ensg%3D%3D Occurrence Handle10.1056/NEJM199903113401001
C. L. Lai P. C. Wu G. C. Chan A. S. Lok H. J. Lin (1988) ArticleTitleDoxorubicin versus no antitumor therapy in inoperable hepatocellular carcinoma. A prospective randomized trial Cancer 62 479–483 Occurrence Handle2839280 Occurrence Handle1:STN:280:DyaL1c3ntVeisg%3D%3D Occurrence Handle10.1002/1097-0142(19880801)62:3<479::AID-CNCR2820620306>3.0.CO;2-L
L. Barraud P. Merle E. Soma L. Lefrançois S. Guerret M. Chevallier C. Dubernet P. Couvreur C. Trepo L. Vitvitski (2005) ArticleTitleIncrease of doxorubicin sensitivity by doxorubicin-loading into nanoparticles for hepatocellular carcinoma cells in vitro and in vivo J. Hepatol. 42 736–743 Occurrence Handle15826724 Occurrence Handle1:CAS:528:DC%2BD2MXjtFyktLk%3D Occurrence Handle10.1016/j.jhep.2004.12.035
A. Gabizon S. Amselem D. Gorem R. Cohen S. Druckmann I. Fromer R. Chisin A. Peretz Y. Barenholz (1990) ArticleTitlePreclinical and clinical experience with a doxorubicin liposome preparation J. Liposome Res. 1 491–502
A. Gabizon T. Peretz A. Sulkes S. Amselem R. Ben-Yosef N. Ben-Baruch R. Catane S. Biran Y. Barenholz (1989) ArticleTitleSystemic administration of doxorubicin-containing liposomes in cancer patients: a phase I study Eur. J. Cancer Clin. Oncol. 25 1795–1803 Occurrence Handle2632261 Occurrence Handle1:STN:280:DyaK3c3hsVKltA%3D%3D Occurrence Handle10.1016/0277-5379(89)90350-7
M. C. Woodle D. D. Lasic (1992) ArticleTitleSterically stabilized liposomes Biochim. Biophys. Acta 1113 171–199 Occurrence Handle1510996 Occurrence Handle1:CAS:528:DyaK38XltlOnu78%3D
D. Papahadjopoulos T. M. Allen A. Gabizon E. Mayhew K. Matthay S. K. Huang K. Lee M. C. Woodle D. D. Lasic C. Redemann M. F. Martin (1991) ArticleTitleSterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy Proc. Natl. Acad. Sci. USA 88 11460–11464 Occurrence Handle1763060 Occurrence Handle1:CAS:528:DyaK38XmslWjsg%3D%3D Occurrence Handle10.1073/pnas.88.24.11460
S. I. Jeon J. H. Lee J. D. Andrade P. G. Gennes ParticleDe (1991) ArticleTitleProtein–surface interactions in the presence of polyethylene oxide. I Simplified theory J. Colloid Interface Sci. 142 149–158 Occurrence Handle1:CAS:528:DyaK3MXovVKisg%3D%3D Occurrence Handle10.1016/0021-9797(91)90043-8
A. Gabizon R. Catane B. Uziely B. Kaufman T. Safra R. Cohen F. Martin A. Huang Y. Barenholz (1994) ArticleTitleProlonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes Cancer Res. 54 987–992 Occurrence Handle8313389 Occurrence Handle1:CAS:528:DyaK2cXhslegs70%3D
L. Illum L. O. Jacobsen R. H. Muller E. Mak S. S. Davis (1987) ArticleTitleSurface characteristics and the interaction of colloidal particles with mouse peritoneal macrophages Biomaterials 8 113–117 Occurrence Handle3580470 Occurrence Handle1:CAS:528:DyaL2sXitF2ntLY%3D Occurrence Handle10.1016/0142-9612(87)90099-8
S. M. Moghimi I. S. Muir L. Illum S. S. Davis V. Kolb-Bachofen (1993) ArticleTitleCoating particles with a block co-polymer (poloxamine-908) suppresses opsonization but permits the activity of dysopsonins in the serum Biochim. Biophys. Acta 1179 157–165 Occurrence Handle8218358 Occurrence Handle1:CAS:528:DyaK2cXjsl2ntw%3D%3D Occurrence Handle10.1016/0167-4889(93)90137-E
R. Gref Y. Minamitake M. T. Peracchia V. Trubetskoy V. Torchilin R. Langer (1994) ArticleTitleBiodegradable long-circulating polymeric nanospheres Science 263 1600–1603 Occurrence Handle8128245 Occurrence Handle1:CAS:528:DyaK2cXit1KktLc%3D
M. T. Peracchia S. Harnisch H. Pinto-Alphandary A. Gulik J. C. Dedieu D. Desmaële J. D’Angelo R. H. Müller P. Couvreur (1999) ArticleTitleVisualization of in vitro protein-rejecting properties of PEGylated stealth polycyanoacrylate nanoparticle Biomaterials 20 1269–1275 Occurrence Handle10403044 Occurrence Handle1:CAS:528:DyaK1MXktVyjtbk%3D Occurrence Handle10.1016/S0142-9612(99)00021-6
G. Storm S. O. Belliot T. Daemen D. D. Lasic (1995) ArticleTitleSurface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system Adv. Drug Deliv. Rev. 17 31–48 Occurrence Handle1:CAS:528:DyaK2MXps1Wltbk%3D Occurrence Handle10.1016/0169-409X(95)00039-A
S. M. Moghimi A. C. Hunter J. C. Murray (2001) ArticleTitleLong-circulating and target-specific nanoparticles: theory to practice Pharmacol. Rev. 53 283–318 Occurrence Handle11356986 Occurrence Handle1:CAS:528:DC%2BD3MXkt1Gnurc%3D
H. F. Dvorak J. A. Nagy J. T. Dvorak A. M. Dvorak (1988) ArticleTitleIdentification and characterization of the blood vessels of solid tumors that are leaky to circulating macromolecules Am. J. Pathol. 133 95–109 Occurrence Handle2459969 Occurrence Handle1:STN:280:DyaL1M%2FitlCksQ%3D%3D
Y. Noguchi J. Wu R. Duncan J. Strohalm K. Ulbrich T. Akaike H. Maeda (1998) ArticleTitleEarly phase tumor accumulation of macromolecules: a great difference in clearance rate between tumor and normal tissues Jpn. J. Cancer Res. 89 307–314 Occurrence Handle9600125 Occurrence Handle1:CAS:528:DyaK1cXis1arsbY%3D
H. Maeda J. Wu T. Sawa Y. Matsumura K. Hori (2000) ArticleTitleTumor vascular permeability and the EPR effect in macromolecular therapeutics: a review J. Control. Release 65 271–284 Occurrence Handle10699287 Occurrence Handle1:CAS:528:DC%2BD3cXhtl2qsLo%3D Occurrence Handle10.1016/S0168-3659(99)00248-5
P. Calvo B. Gouritin H. Villarroya F. Eclancher C. Giannavola C. Klein J. P. Andreux P. Couvreur (2002) ArticleTitleQuantification and localization of PEGylated polycyanoacrylate nanoparticles in brain and spinal cord during experimental allergic encephalomyelitis in the rat Eur. J. Neurosci. 15 1317–1326 Occurrence Handle11994126 Occurrence Handle10.1046/j.1460-9568.2002.01967.x
P. G. Rose (2005) ArticleTitlePegylated liposomal doxorubicin: optimizing the dosing schedule in ovarian cancer Oncologist 10 205–214 Occurrence Handle15793224 Occurrence Handle1:CAS:528:DC%2BD2MXjsFSnsbg%3D Occurrence Handle10.1634/theoncologist.10-3-205
A. N. Gordon C. O. Granai P. G. Rose J. Hainsworth A. Lopez C. Weissman R. Rosales T. Sharpington (2000) ArticleTitlePhase II study of liposomal doxorubicin in platinum- and paclitaxel-refractory epithelial ovarian cancer J. Clin. Oncol. 18 3093–3100 Occurrence Handle10963637 Occurrence Handle1:CAS:528:DC%2BD3cXntVCgsb4%3D
A. N. Gordon J. T. Fleagle D. Guthrie D. E. Parkin M. E. Gore A. J. Lacave (2001) ArticleTitleRecurrent epithelial ovarian carcinoma: a randomized phase III study of pegylated liposomal doxorubicin versus topotecan J. Clin. Oncol. 19 3312–3322 Occurrence Handle11454878 Occurrence Handle1:CAS:528:DC%2BD3MXlvVamsr8%3D
O. Lyass B. Uziely R. Ben Yosef D. Tzemach N. I. Heshing M. Lotem G. Brufman A. Gabizon (2000) ArticleTitleCorrelation of toxicity with pharmacokinetics of pegylated liposomal doxorubicin (Doxil) in metastatic breast carcinoma Cancer 89 1037–1047 Occurrence Handle10964334 Occurrence Handle1:CAS:528:DC%2BD3cXmsFSqs7o%3D Occurrence Handle10.1002/1097-0142(20000901)89:5<1037::AID-CNCR13>3.0.CO;2-Z
J. M. Ferrero B. Weber D. Lepille H. Orfeuvre M. Combe F. Mayer B. Leduc H. Bourgeois D. Paraiso E. Pujate-Lauraine (2004) ArticleTitleCarboplatin (PA) and pegylated liposomal doxorubicin in patients with advanced ovarian cancer in late (>6 months) relapse (AOCLR): survival results of a GINECO phase II trial Proc. Am. Soc. Clin. Oncol. 23 467s
P. Sapra T. M. Allen (2002) ArticleTitleInternalizing antibodies are necessary for improved therapeutic efficacy of antibody-targeted liposomal drugs Cancer Res. 62 7190–7194 Occurrence Handle12499256 Occurrence Handle1:CAS:528:DC%2BD3sXhtVyrtQ%3D%3D
P. Sapra T. M. Allen (2003) ArticleTitleLigand-targeted liposomal anticancer drugs Prog. Lipid Res. 42 439–462 Occurrence Handle12814645 Occurrence Handle1:CAS:528:DC%2BD3sXks1altLY%3D Occurrence Handle10.1016/S0163-7827(03)00032-8
V. P. Torchilin (2005) ArticleTitleRecent advances with liposomes as pharmaceutical carriers Nat. Rev. Drug Discov. 4 145–160 Occurrence Handle15688077 Occurrence Handle1:CAS:528:DC%2BD2MXpt1WlsA%3D%3D Occurrence Handle10.1038/nrd1632
T. L. Andresen S. S. Jensen K. Jorgensen (2005) ArticleTitleAdvanced strategies in liposomal cancer therapy: problems and prospects of active and tumor specific drug release Prog. Lipid Res. 44 68–97 Occurrence Handle15748655 Occurrence Handle1:CAS:528:DC%2BD2MXhvVCjtb8%3D Occurrence Handle10.1016/j.plipres.2004.12.001
K. Maruyama O. Ishida T. Takizawa K. Moribe (1999) ArticleTitlePossibility of active targeting to tumor tissues with liposomes Adv. Drug Deliv. Rev. 40 89–102 Occurrence Handle10837782 Occurrence Handle1:CAS:528:DyaK1MXmsFajsLc%3D Occurrence Handle10.1016/S0169-409X(99)00042-3
J. W. Park D. B. Kirpotin K. Hong R. Shalaby Y. Shao U. B. Nielsen J. D. Marks D. Papahadjopoulos C. C. Benz (2001) ArticleTitleTumor targeting using anti-her2 immunoliposomes J. Control. Release 74 95–113 Occurrence Handle11489487 Occurrence Handle1:CAS:528:DC%2BD3MXlslansrk%3D Occurrence Handle10.1016/S0168-3659(01)00315-7
J. A. Kamps G. A. Koning M. J. Velinova H. W. Morselt M. Wilkens A. Gorter J. Donga G. L. Scherphof (2000) ArticleTitleUptake of long-circulating immunoliposomes, directed against colon adenocarcinoma cells, by liver metastases of colon cancer J. Drug Target. 8 235–245 Occurrence Handle11144234 Occurrence Handle1:CAS:528:DC%2BD3cXoslaitbg%3D Occurrence Handle10.3109/10611860008997902
G. A. Koning H. W. M. Morselt A. Gorter T. M. Allen S. Zalipsky G. L. Scherphof J. A. A. M. Kamps (2003) ArticleTitleInteraction of differently designed immunoliposomes with colon cancer cells and Kupffer cells. An in vitro comparison Pharm. Res. 20 1249–1257 Occurrence Handle12948023 Occurrence Handle1:CAS:528:DC%2BD3sXmtVGrtb0%3D Occurrence Handle10.1023/A:1025009300562
R. M. Schiffelers G. A. Koning T. L. M. Hagen ParticleTen M. H. A. M. Fens A. J. Schraa A. P. C. A. Janssen R. J. Kok G. Molema G. Storm (2003) ArticleTitleAnti-tumor efficacy of tumor vasculature-targeted liposomal doxorubicin J. Control. Release 91 115–122 Occurrence Handle12932643 Occurrence Handle1:CAS:528:DC%2BD3sXmsVSkurw%3D Occurrence Handle10.1016/S0168-3659(03)00240-2
J. N. Moreira T. Ishida R. Gaspar T. M. Allen (2002) ArticleTitleUse of the post-insertion technique to insert peptide ligands into pre-formed stealth liposomes with retention of binding activity and cytotoxicity Pharm. Res. 19 265–269 Occurrence Handle11934232 Occurrence Handle1:CAS:528:DC%2BD38XisFGgu74%3D Occurrence Handle10.1023/A:1014434732752
H. Hatakeyama H. Akita K. Maruyama T. Suhara H. Harashima (2004) ArticleTitleFactors governing the in vivo tissue uptake of transferrin-coupled polyethylene glycol liposomes in vivo Int. J. Pharm. 281 25–33 Occurrence Handle15288340 Occurrence Handle1:CAS:528:DC%2BD2cXmtFCmurk%3D Occurrence Handle10.1016/j.ijpharm.2004.05.025
D. A. Eavarone X. Yu R. V. Bellamkonda (2000) ArticleTitleTargeted drug delivery to C6 glioma by transferrin-coupled liposomes J. Biomed. Mater. Res. 51 10–14 Occurrence Handle10813739 Occurrence Handle1:CAS:528:DC%2BD3cXjsFygsbc%3D Occurrence Handle10.1002/(SICI)1097-4636(200007)51:1<10::AID-JBM2>3.0.CO;2-R
O. Ishida K. Maruyama H. Tanahashi M. Iwatsuru K. Sasaki M. Eriguchi H. Yanagie (2001) ArticleTitleLiposomes bearing polyethyleneglycol-coupled transferrin with intracellular targeting property to the solid tumors in vivo Pharm. Res. 18 1042–1048 Occurrence Handle11496943 Occurrence Handle1:CAS:528:DC%2BD3MXlsV2itbo%3D Occurrence Handle10.1023/A:1010960900254
R. J. Lee P. S. Low (1994) ArticleTitleDelivery of liposomes into cultured KB cells via folate receptor-mediated endocytosis J. Biol. Chem. 269 3198–3204 Occurrence Handle8106354 Occurrence Handle1:CAS:528:DyaK2cXhsVeqsbk%3D
S. Ni S. M. Stephenson R. J. Lee (2002) ArticleTitleFolate receptor targeted delivery of liposomal daunorubicin into tumor cells Anticancer Res. 22 2131–2135 Occurrence Handle12174894 Occurrence Handle1:CAS:528:DC%2BD38XmsF2ltrY%3D
X. Q. Pan H. Wang R. J. Lee (2003) ArticleTitleAntitumor activity of folate receptor-targeted liposomal doxorubicin in a KB oral carcinoma murine xenograft model Pharm. Res. 20 417–422 Occurrence Handle12669962 Occurrence Handle1:CAS:528:DC%2BD3sXhslGrtrw%3D Occurrence Handle10.1023/A:1022656105022
J. J. Sudimack D. Adams J. Rotaru S. Shukla J. Yan M. Sekido R. F. Barth W. Tjarks R. J. Lee (2002) ArticleTitleFolate receptor-mediated liposomal delivery of a lipophilic boron agent to tumor cells in vitro for neutron capture therapy Pharm. Res. 19 1502–1508 Occurrence Handle12425468 Occurrence Handle1:CAS:528:DC%2BD38XnsFSgsbY%3D Occurrence Handle10.1023/A:1020408716807
P. Opanasopit M. Sakai M. Nishikawa S. Kawakami F. Yamashita M. Hashida (2002) ArticleTitleInhibition of liver metastasis by targeting of immunomodulators using mannosylated liposome carriers J. Control. Release 80 283–294 Occurrence Handle11943405 Occurrence Handle1:CAS:528:DC%2BD38XisFyrsbg%3D Occurrence Handle10.1016/S0168-3659(02)00006-8
B. Stella S. Arpicco M. T. Peracchia D. Desmaele J. Hoebeke M. Renoir J. D’Angelo L. Cattel P. Couvreur (2000) ArticleTitleDesign of folic acid-conjugated nanoparticles for drug targeting J. Pharm. Sci. 89 1452–1464 Occurrence Handle11015690 Occurrence Handle1:CAS:528:DC%2BD3cXnvVygtrw%3D Occurrence Handle10.1002/1520-6017(200011)89:11<1452::AID-JPS8>3.0.CO;2-P
H. Wartlick K. Michaelis S. Balthasar K. Strebhardt J. Kreuter K. Langer (2004) ArticleTitleHighly specific HER2-mediated cellular uptake of antibody-modified nanoparticles in tumour cells J. Drug Target. 12 461–471 Occurrence Handle15621671 Occurrence Handle1:CAS:528:DC%2BD2cXhtFSisLfE Occurrence Handle10.1080/10611860400010697
M. B. Yatvin W. Kreutz B. A. Horwitz M. Shinitzky (1980) ArticleTitlepH-sensitive liposomes: possible clinical implications Science 210 1253–1255 Occurrence Handle7434025 Occurrence Handle1:CAS:528:DyaL3MXhsVGhurw%3D
J. Shin P. Shum D. H. Thompson (2003) ArticleTitleAcid-triggered release via dePEGylation of DOPE liposomes containing acid-labile vinyl ether PEG-lipids J. Control. Release 91 187–200 Occurrence Handle12932651 Occurrence Handle1:CAS:528:DC%2BD3sXmsVSrsrw%3D Occurrence Handle10.1016/S0168-3659(03)00232-3
G. Helmlinger F. Yuan M. Dellian R. K. Jain (1997) ArticleTitleInterstitial pH and pO2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation Nat. Med. 3 177–182 Occurrence Handle9018236 Occurrence Handle1:CAS:528:DyaK2sXpsVOktw%3D%3D Occurrence Handle10.1038/nm0297-177
G. Helmlinger A. Sckell M. Dellian N. S. Forbes R. K. Jain (2002) ArticleTitleAcid production in glycolysis-impaired tumors provides new insights into tumor metabolism Clin. Cancer Res. 8 1284–1291 Occurrence Handle11948144 Occurrence Handle1:CAS:528:DC%2BD38XjsF2ltb4%3D
E. Fattal P. Couvreur C. Dubernet (2004) ArticleTitle“Smart” delivery of antisense oligonucleotides by anionic pH-sensitive liposomes Adv. Drug Deliv. Rev. 56 931–946 Occurrence Handle15066753 Occurrence Handle1:CAS:528:DC%2BD2cXivVGitLs%3D Occurrence Handle10.1016/j.addr.2003.10.037
S. Simoes J. N. Moreira C. Fonseca N. Düzgünes M. C. Pedroso de Lima (2004) ArticleTitleOn the formulation of pH-sensitive liposomes with long circulation times Adv. Drug Deliv. Rev. 56 947–965 Occurrence Handle15066754 Occurrence Handle1:CAS:528:DC%2BD2cXivVGitLg%3D Occurrence Handle10.1016/j.addr.2003.10.038
A. Mori A. L. Klibanov V. P. Torchilin L. Huang (1991) ArticleTitleInfluence of the steric barrier activity of amphipathic poly(ethyleneglycol) and ganglioside GM1 on the circulation time of liposomes and on the target binding of immunoliposomes in vivo FEBS Lett. 284 263–266 Occurrence Handle2060647 Occurrence Handle1:CAS:528:DyaK3MXkslyrsr4%3D Occurrence Handle10.1016/0014-5793(91)80699-4
K. Kono K. Zenitani T. Takagishi (1994) ArticleTitleNovel pH-sensitive liposomes: liposomes bearing a poly(ethylene glycol) derivative with carboxyl groups Biochim. Biophys. Acta 1193 1–9 Occurrence Handle8038177 Occurrence Handle1:CAS:528:DyaK2cXls1ertrY%3D Occurrence Handle10.1016/0005-2736(94)90325-5
E. Roux M. Francis F. M. Winnik J. C. Leroux (2002) ArticleTitlePolymer based pH-sensitive carriers as a means to improve the cytoplasmic delivery of drugs Int. J. Pharm. 242 25–36 Occurrence Handle12176222 Occurrence Handle1:CAS:528:DC%2BD38Xmt1ygur8%3D Occurrence Handle10.1016/S0378-5173(02)00183-7
D. Collins D. C. Litzinger L. Huang (1990) ArticleTitleStructural and functional comparisons of pH-sensitive liposomes composed of phosphatidylethanolamine and three different diacylsuccinylglycerols Biochim. Biophys. Acta 1025 234–242 Occurrence Handle2364079 Occurrence Handle1:CAS:528:DyaK3cXlvFOktLY%3D Occurrence Handle10.1016/0005-2736(90)90102-T
K. Kono T. Igawa T. Takagishi (1997) ArticleTitleCytoplasmic delivery of calcein mediated by liposomes modified with a pH-sensitive poly(ethylene glycol) derivative Biochim. Biophys. Acta 1325 143–154 Occurrence Handle9168140 Occurrence Handle1:CAS:528:DyaK2sXjt1WrsrY%3D Occurrence Handle10.1016/S0005-2736(96)00244-1
V. A. Slepushkin S. Simoens P. Dazin M. S. Newman L. S. Guo M. C. Pedroso de Lima N. Duzgunes (1997) ArticleTitleSterically stabilized pH-sensitive liposomes. Intracellular delivery of aqueous contents and prolonged circulation in vivo J. Biol. Chem. 272 2382–2388 Occurrence Handle8999949 Occurrence Handle1:CAS:528:DyaK2sXotFarsg%3D%3D Occurrence Handle10.1074/jbc.272.4.2382
D. Liu L. Huang (1990) ArticleTitlepH-Sensitive, plasma-stable liposomes with relatively prolonged residence in circulation Biochim. Biophys. Acta 1022 348–354 Occurrence Handle2317486 Occurrence Handle1:CAS:528:DyaK3cXhvVGks7Y%3D Occurrence Handle10.1016/0005-2736(90)90284-U
M. B. Yatvin J. N. Weinstein W. H. Dennis R. Blumenthal (1978) ArticleTitleDesign of liposomes for enhanced local release of drugs by hyperthermia Science 202 1290–1293 Occurrence Handle364652 Occurrence Handle1:CAS:528:DyaE1MXpt1elsQ%3D%3D
G. Kong G. Anyarambhatla W. P. Petros R. D. Braun O. M. Colvin D. Needham M. W. Dewhirst (2000) ArticleTitleEfficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release Cancer Res. 60 6950–6957 Occurrence Handle11156395 Occurrence Handle1:CAS:528:DC%2BD3MXjsVOjtA%3D%3D
D. Needham G. Anyarambhatla G. Kong M. W. Dewhirs (2000) ArticleTitleA new temperature-sensitive liposome for use with mild hyperthermia: characterization and testing in a human tumor xenograft model Cancer Res. 60 1197–1201 Occurrence Handle10728674 Occurrence Handle1:CAS:528:DC%2BD3cXhvFWrsb0%3D
T. L. Andresen J. Davidsen M. Begtrup O. G. Mouritsen K. Jorgensen (2004) ArticleTitleEnzymatic release of antitumor ether lipids by specific phospholipase A2 activation of liposome-forming prodrugs J. Med. Chem. 47 1694–1703 Occurrence Handle15027860 Occurrence Handle1:CAS:528:DC%2BD2cXhsVOit70%3D Occurrence Handle10.1021/jm031029r
T. L. Andresen O. G. Mouritsen M. Begtrup K. Jorgensen (2002) ArticleTitlePhospholipase A2 activity: dependence on liposome surface charge and polymer coverage Biophys. J. 82 148c
C. C. Pak R. K. Erukulla P. L. Ahl A. S. Janoff P. Meers (1999) ArticleTitleElastase activated liposomal delivery to nucleated cells Biochim. Biophys. Acta 1419 111–126 Occurrence Handle10407064 Occurrence Handle1:CAS:528:DyaK1MXltV2mtLk%3D Occurrence Handle10.1016/S0005-2736(98)00256-9
S. C. Davis F. C. Szoka SuffixJr. (1998) ArticleTitleCholesterol phosphate derivatives: synthesis and incorporation into a phosphatase and calcium-sensitive triggered release liposome Bioconjug. Chem. 9 783–792 Occurrence Handle9815173 Occurrence Handle1:CAS:528:DyaK1cXmsVWjs7w%3D Occurrence Handle10.1021/bc980047y
A. Mueller B. Bondurant D. F. O’Brien (2000) ArticleTitleVisible-light stimulated destabilization of PEG-liposomes Macromolecules 33 4799–4804 Occurrence Handle1:CAS:528:DC%2BD3cXjs1KksL4%3D Occurrence Handle10.1021/ma000055l
B. Bonnemain (1998) ArticleTitleSuperparamagnetic agents in magnetic resonance imaging: physicochemical characteristics and clinical applications. A review J. Drug Target. 6 167–174 Occurrence Handle9888302 Occurrence Handle1:CAS:528:DyaK1MXkvFKguw%3D%3D Occurrence Handle10.3109/10611869808997890
D. Pouliquen J. J. Jeune ParticleLe R. Perdrisot A. Ermias P. Jallet (1991) ArticleTitleIron oxide nanoparticles for use as an MRI contrast agent: pharmacokinetics and metabolism Magn. Reson. Imaging 9 275–283 Occurrence Handle1881245 Occurrence Handle1:CAS:528:DyaK3MXlslyhtbw%3D Occurrence Handle10.1016/0730-725X(91)90412-F
E. Okon D. Pouliquen P. Okon Z. V. Kovaleva T. P. Stepanova S. G. Lavit B. N. Kudryavtsev P. Jallet (1994) ArticleTitleBiodegradation of magnetite dextran nanoparticles in the rat. A histologic and biophysical study Lab. Invest. 71 895–903 Occurrence Handle7807971 Occurrence Handle1:CAS:528:DyaK2MXjs12gsbg%3D
A. Chachuat B. Bonnemain (1995) ArticleTitleEuropean clinical experience with Endorem. A new contrast agent for liver MRI in 1000 patients Radiology 35 S274–S276 Occurrence Handle1:STN:280:DyaK287gvVansw%3D%3D
S. Kubaska D. V. Sahani S. Saini P. F. Hahn E. Halpern (2001) ArticleTitleDual contrast enhanced magnetic resonance imaging of the liver with superparamagnetic iron oxide followed by gadolinium for lesion detection and characterisation Clin. Radiol. 56 410–415 Occurrence Handle11384141 Occurrence Handle1:STN:280:DC%2BD3MzhtFKlsA%3D%3D Occurrence Handle10.1053/crad.2000.0673
R. Weissleder G. Elizondo D. D. Stark P. F. Hahn J. Marfil J. F. Gonzalez S. Saini L. E. Todd J. T. Ferrucci (1989) ArticleTitleThe diagnosis of splenic lymphoma by MR imaging: value of superparamagnetic iron oxide A.J.R. Am. J. Roentgenol. 152 175–180 Occurrence Handle1:STN:280:DyaL1M%2FnsVCqsg%3D%3D
A. Iannone R. L. Magin T. Walczak M. Federico H. M. Swartz A. Tomasi V. Vannini (1991) ArticleTitleBlood clearance of dextran magnetite particles determined by a noninvasive in vivo ESR method Magn. Reson. Med. 22 435–442 Occurrence Handle1725919 Occurrence Handle1:STN:280:DyaK383lt1Kqsg%3D%3D
R. Weissleder A. Bogdanov E. A. Neuwelt M. Papisov (1995) ArticleTitleLong-circulating iron oxides for MR imaging Adv. Drug Deliv. Rev. 16 321–334 Occurrence Handle1:CAS:528:DyaK2MXpt1amt7s%3D Occurrence Handle10.1016/0169-409X(95)00033-4
K. Turetschek S. Huber E. Floyd T. Helbich T. P. Roberts D. M. Shames K. S. Tarlo M. F. Wendland R. C. Brasch (2001) ArticleTitleMR imaging characterization of microvessels in experimental breast tumors by using a particulate contrast agent with histopathologic correlation Radiology 218 562–569 Occurrence Handle11161179 Occurrence Handle1:STN:280:DC%2BD3M3lvVehsw%3D%3D
Y. Anzai S. McLachlan M. Morris R. Saxton R. B. Lufkin (1994) ArticleTitleDextran-coated superparamagnetic iron oxide, an MR contrast agent for assessing lymph nodes in the head and neck Am. J. Neuroradiol. 15 87–94 Occurrence Handle7511324 Occurrence Handle1:STN:280:DyaK2c7ovFCkug%3D%3D
K. Lind M. Kresse N. P. Debus R. H. Muller (2002) ArticleTitleA novel formulation for superparamagnetic iron oxide (SPIO) particles enhancing MR lymphograpy: comparison of physicochemical properties and the in vivo behaviour J. Drug Target. 10 221–230 Occurrence Handle12075823 Occurrence Handle1:CAS:528:DC%2BD38XjslSlt7s%3D Occurrence Handle10.1080/10611860290022651
A. Moore R. Weissleder A. Bogdanov SuffixJr. (1997) ArticleTitleUptake of dextran-coated monocrystalline iron oxides in tumor cells and macrophages J. Magn. Reson. Imaging 7 1140–1145 Occurrence Handle9400860 Occurrence Handle1:STN:280:DyaK1c%2Fmt1SgsA%3D%3D
A. Moore J. P. Basilion E. A. Chiocca R. Weissleder (1998) ArticleTitleMeasuring transferrin receptor gene expression by NMR imaging Biochim. Biophys. Acta 1402 239–249 Occurrence Handle9606982 Occurrence Handle1:CAS:528:DyaK1cXivVOqtLY%3D Occurrence Handle10.1016/S0167-4889(98)00002-0
P. Varallyay G. Nesbit L. L. Muldoon R. R. Nixon J. Delashaw J. I. Cohen A. Petrillo D. Rink E. A. Neuwelt (2002) ArticleTitleComparison of two superparamagnetic viral-sized iron oxide particles ferumoxides and ferumoxtran-10 with a gadolinium chelate in imaging intracranial tumors Am. J. Neuroradiol. 23 510–519 Occurrence Handle11950637
L. G. Remsen C. I. McCormick S. Roman-Goldstein G. Nilaver R. Weissleder A. Bogdanov I. Hellstrom R. A. Kroll E. A. Neuwelt (1996) ArticleTitleMR of carcinoma-specific monoclonal antibody conjugated to monocrystalline iron oxide nanoparticles: the potential for noninvasive diagnosis Am. J. Neuroradiol. 17 411–418 Occurrence Handle8881233 Occurrence Handle1:STN:280:DyaK2s%2FjsFGrtw%3D%3D
D. Artemov N. Mori B. Okollie Z. M. Bhujwalla (2003) ArticleTitleMR molecular imaging of the Her-2/neu receptor in breast cancer cells using targeted iron oxide nanoparticles Magn. Reson. Med. 49 403–408 Occurrence Handle12594741 Occurrence Handle1:CAS:528:DC%2BD3sXisVGktL4%3D Occurrence Handle10.1002/mrm.10406
M. Shinkai M. Yanase M. Suzuki H. Honda T. Wakabayashi J. Yoshida T. Kobayashi (1999) ArticleTitleIntracellular hyperthermia for cancer using magnetite cationic liposomes J. Magn. Magn. Mater. 194 176–184 Occurrence Handle1:CAS:528:DyaK1MXitVKltrs%3D Occurrence Handle10.1016/S0304-8853(98)00586-1
M. Yanase M. Shinkai H. Honda T. Wakabayashi J. Yoshida T. Kobayashi (1998) ArticleTitleAntitumor immunity induction by intracellular hyperthermia using magnetite cationic liposomes Jpn. J. Cancer Res. 89 775–782 Occurrence Handle9738985 Occurrence Handle1:CAS:528:DyaK1cXltlCju78%3D
I. Hilger W. Andrä R. Hergt R. Hiergeist H. Schubert W. A. Kaiser (2001) ArticleTitleElectromagnetic heating of breast tumors in interventional radiology: in vitro and in vivo studies in human cadavers and mice Radiology 218 570–575 Occurrence Handle11161180 Occurrence Handle1:STN:280:DC%2BD3M3lvVehsA%3D%3D
A. Jordan P. Wust R. Scholz H. Faehling J. Krause R. Felix (1997) Magnetic fluid hyperthermia (MFH) U. Hafeli W. Schutt J. Teller U. Hdfeli W. Schutt M. Zborowski (Eds) Scientific and Clinical Applications of Magnetic Carriers Plenum Press New York 569–595
A. Jordan R. Scholz K. Maier-Hauff M. Johannsen P. Wust J. Nadobny H. Schirra H. Schmidt S. Deger S. Loening W. Lanksch R. Felix (2001) ArticleTitlePresentation of a new magnetic field therapy system for the treatment of human solid tumors with magnetic fluid hyperthermia J. Magn. Magn. Mater. 225 118–126 Occurrence Handle1:CAS:528:DC%2BD3MXislaiurc%3D Occurrence Handle10.1016/S0304-8853(00)01239-7
A. Halbreich J. Roger J. N. Pons D. Geldwerth M. F. Silva ParticleDa M. Roudier J. C. Bacri (1998) ArticleTitleBiomedical applications of maghemite ferrofluid Biochimie 80 379–390 Occurrence Handle9782379 Occurrence Handle1:CAS:528:DyaK1cXmt1Sntbw%3D Occurrence Handle10.1016/S0300-9084(00)80006-1
J. C. Bacri M. F. Silva ParticleDa R. Perzynski J. N. Pons J. Roger D. Sabolovic A. Halbreich (1997) Use of magnetic nanoparticles for thermolysis of cells in a ferrofluid U. Hafeli W. Schutt J. Teller U. Hdfeli W. Schutt M. Zborowski (Eds) Scientific and Clinical Applications of Magnetic Carriers Plenum Press New York 597–606
A. Jordan R. Scholz P. Wust H. Schirra (1999) ArticleTitleEndocytosis of dextran and silan-coated magnetite nanoparticles and the effect of intracellular hyperthermia on human mammary carcinoma cells in vitro J. Magn. Magn. Mater. 194 185–196 Occurrence Handle1:CAS:528:DyaK1MXitVKltrg%3D Occurrence Handle10.1016/S0304-8853(98)00558-7
M. Shinkai B. Le H. Honda K. Yoshikawa K. Shimizu S. Saga T. Wakabayashi J. Yoshida T. Kobayashi (2001) ArticleTitleTargeting hyperthermia for renal cell carcinoma using human MN antigen-specific magnetoliposomes Jpn. J. Cancer Res. 92 1138–1145 Occurrence Handle11676866 Occurrence Handle1:CAS:528:DC%2BD3MXptVGgu7g%3D
F. Sonvico S. Mornet S. Vasseur C. Dubernet D. Jaillard J. Degrouard J. Hoebeke E. Duguet P. Colombo P. Couvreur (2005) ArticleTitleFolate-conjugated iron oxide nanoparticles for solid tumor targeting as potential “Specific Magnetic Hyperthermia Mediators: Synthesis, Physicochemical Characterization, and in Vitro Experiments” Bioconjug. Chem. 16 1181–1188 Occurrence Handle16173796 Occurrence Handle1:CAS:528:DC%2BD2MXpsleqsrs%3D Occurrence Handle10.1021/bc050050z
C. M. Pitsillides E. K. Joe X. Wie R. R. Anderson C. P. Lin (2003) ArticleTitleSelective cell targeting with light-adsorbing microparticles and nanoparticles Biophys. J. 84 4023–4032 Occurrence Handle12770906 Occurrence Handle1:CAS:528:DC%2BD3sXksVKnsbg%3D Occurrence Handle10.1016/S0006-3495(03)75128-5
C. P. Lin M. W. Kelly S. A. Sibayan M. A. Latina R. R. Anderson (1999) ArticleTitleSelective cell killing by microparticle absorption of pulsed laser radiation IEEE J. Sel. Top. Quantum Electron. 5 963–968 Occurrence Handle1:CAS:528:DyaK1MXntVWrurw%3D Occurrence Handle10.1109/2944.796318
F. Shi A. L. Rakhmilevich C. P. Heise K. Oshikawa P. M. Sondel N. S. Yang D. M. Mahvi (2002) ArticleTitleIntratumoral injection of interleukin-12 plasmid DNA, either naked or in complex with cationic lipid, results in similar tumor regression in a murine model Mol. Cancer Ther. 1 949–957 Occurrence Handle12481417 Occurrence Handle1:CAS:528:DC%2BD3sXmvFOntA%3D%3D
K. Kawabata T. Takakura M. Hashida (1995) ArticleTitleThe fate of plasmid DNA after intravenous injection in mice: involvement of scavenger receptors in its hepatic uptake Pharm. Res. 12 825–830 Occurrence Handle7667185 Occurrence Handle1:CAS:528:DyaK2MXmtV2qurc%3D Occurrence Handle10.1023/A:1016248701505
K. Ewert A. Ahmad H. M. Evans H. W. Schmidt C. R. Safinya (2002) ArticleTitleEfficient synthesis and cell-transfection properties of a new multivalent cationic lipid for nonviral gene delivery J. Med. Chem. 45 5023–5029 Occurrence Handle12408712 Occurrence Handle1:CAS:528:DC%2BD38XnvV2lurw%3D Occurrence Handle10.1021/jm020233w
H. Gao K. M. Hui (2001) ArticleTitleSynthesis of a novel series of cationic lipids that can act as efficient gene delivery vehicles through systematic heterocyclic substitution of cholesterol derivatives Gene Ther. 8 855–863 Occurrence Handle11423933 Occurrence Handle1:CAS:528:DC%2BD3MXktFOrtr0%3D Occurrence Handle10.1038/sj.gt.3301471
X. Gao L. Huang (1996) ArticleTitlePotentiation of cationic liposome-mediated gene delivery by polycations Biochemistry 35 1027–1036 Occurrence Handle8547238 Occurrence Handle1:CAS:528:DyaK28XhsFKjsA%3D%3D Occurrence Handle10.1021/bi952436a
N. T. Ueno C. Bartholomeusz W. Xia P. Anklesaria E. M. Bruckheimer E. Mebel R. Paul S. Li G. H. Yo L. Huang M. C. Hung (2002) ArticleTitleSystemic gene therapy in human xenograft tumor models by liposomal delivery of the E1A gene Cancer Res. 62 6712–6716 Occurrence Handle12438271 Occurrence Handle1:CAS:528:DC%2BD38XovFOksLc%3D
A. Y. Nikitin M. I. Juarez-Perez S. Li L. Huang W. H. Lee (1999) ArticleTitleRB-mediated suppression of spontaneous multiple neuroendocrine neoplasia and lung metastases in Rb+/− mice Proc. Natl. Acad. Sci. USA 96 3916–3921 Occurrence Handle10097138 Occurrence Handle1:CAS:528:DyaK1MXjslChsLk%3D Occurrence Handle10.1073/pnas.96.7.3916
T. B. Wyman F. Nicol O. Zelphati P. V. Scaria C. Plank F. C. Szoka SuffixJr. (1997) ArticleTitleDesign, synthesis, and characterization of a cationic peptide that binds to nucleic acids and permeabilizes bilayers Biochemistry 36 3008–3017 Occurrence Handle9062132 Occurrence Handle1:CAS:528:DyaK2sXhslGjsr4%3D Occurrence Handle10.1021/bi9618474
G. Y. Wu C. H. Wu (1987) ArticleTitleReceptor-mediated in vitro gene transformation by a soluble DNA carrier system J. Biol. Chem. 262 4429–4432 Occurrence Handle3558345 Occurrence Handle1:CAS:528:DyaL2sXhslShsL0%3D
C. M. Ward M. L. Read L. W. Seymour (2001) ArticleTitleSystemic circulation of poly(l-lysine)/DNA vectors is influenced by polycation molecular weight and type of DNA: differential circulation in mice and rats and the implications for human gene therapy Blood 97 2221–2229 Occurrence Handle11290582 Occurrence Handle1:CAS:528:DC%2BD3MXivFOgt78%3D Occurrence Handle10.1182/blood.V97.8.2221
O. Boussif F. Lezoualc’h M. A. Zanta M. D. Mergny D. Scherman B. Demeneix J. P. Behr (1995) ArticleTitleA versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine Proc. Natl. Acad. Sci. USA 92 7297–7301 Occurrence Handle7638184 Occurrence Handle1:CAS:528:DyaK2MXntlKmt7s%3D Occurrence Handle10.1073/pnas.92.16.7297
A. Kichler C. Leborgne E. Coeytaux O. Danos (2001) ArticleTitlePolyethylenimine-mediated gene delivery: a mechanistic study J. Gene Med. 3 135–144 Occurrence Handle11318112 Occurrence Handle1:STN:280:DC%2BD3MvkslGksQ%3D%3D Occurrence Handle10.1002/jgm.173
H. Lee J. H. Jeong T. G. Park (2002) ArticleTitlePEG grafted polylysine with fusogenic peptide for gene delivery: high transfection efficiency with low cytotoxicity J. Control. Release 79 283–291 Occurrence Handle11853938 Occurrence Handle1:CAS:528:DC%2BD38XhtlSlsbo%3D Occurrence Handle10.1016/S0168-3659(02)00002-0
E. Wagner M. Zenke M. Cotten H. Beug M. L. Birnstiel (1990) ArticleTitleTransferrin-polycation conjugates as carriers for DNA uptake into cells Proc. Natl. Acad. Sci. USA 87 3410–3414 Occurrence Handle2333290 Occurrence Handle1:CAS:528:DyaK3MXitVWjtrc%3D Occurrence Handle10.1073/pnas.87.9.3410
W. Suh J. K. Chung S. H. Park S. W. Kim (2001) ArticleTitleAnti-JL1 antibody-conjugated poly(l-lysine) for targeted gene delivery to leukemia T cells J. Control. Release 72 171–178 Occurrence Handle11389996 Occurrence Handle1:CAS:528:DC%2BD3MXktVGks70%3D Occurrence Handle10.1016/S0168-3659(01)00273-5
C. M. Ward M. Pechar D. Oupicky K. Ulbrich L. W. Seymour (2002) ArticleTitleModification of pLL/DNA complexes with a multivalent hydrophilic polymer permits folate-mediated targeting in vitro and prolonged plasma circulation in vivo J. Gene Med. 4 536–547 Occurrence Handle12221647 Occurrence Handle1:CAS:528:DC%2BD38XosVWru74%3D Occurrence Handle10.1002/jgm.296
R. Kircheis S. Schuller S. Brunner M. Ogris K. H. Heider W. Zauner E. Wagner (1999) ArticleTitlePolycation-based DNA complexes for tumor-targeted gene delivery in vivo J. Gene Med. 1 111–120 Occurrence Handle10738575 Occurrence Handle1:CAS:528:DyaK1MXjvVCmtLk%3D Occurrence Handle10.1002/(SICI)1521-2254(199903/04)1:2<111::AID-JGM22>3.0.CO;2-Y
G. Stingl E. B. Brocker R. Mertelsmann K. Wolff S. Schreiber E. Kampgen A. Schneeberger W. Dummer U. Brennscheid H. Veelken M. L. Birnstiel K. Zatloukal W. Schmidt G. Maass E. Wagner M. Baschle M. Giese E. R. Kempe H. A. Weber T. Voigt (1996) ArticleTitlePhase I study to the immunotherapy of metastatic malignant melanoma by a cancer vaccine consisting of autologous cancer cells transfected with the human IL-2 gene Hum. Gene Ther. 7 551–563 Occurrence Handle8800750 Occurrence Handle1:CAS:528:DyaK28Xit12ht74%3D
J. Chen S. Gamou A. Takayanagi N. Shimizu (1994) ArticleTitleA novel gene delivery system using EGF receptor-mediated endocytosis FEBS Lett. 338 167–169 Occurrence Handle8307175 Occurrence Handle1:CAS:528:DyaK2cXhsFGitbY%3D Occurrence Handle10.1016/0014-5793(94)80357-9
A. Boletta A. Benigni J. Lutz G. Remuzzi M. R. Soria L. Monaco (1997) ArticleTitleNonviral gene delivery to the rat kidney with polyethylenimine Hum. Gene Ther. 8 1243–1251 Occurrence Handle9215741 Occurrence Handle1:CAS:528:DyaK2sXksF2nt70%3D
M. Köping-Höggard Y. S. Mel’nikova K. M. Varum B. Lindman P. Artursson (2003) ArticleTitleRelationship between the physical shape and the efficiency of oligomeric chitosan as a gene delivery system in vitro and in vivo J. Gene Med. 5 130–141 Occurrence Handle12539151 Occurrence Handle10.1002/jgm.327 Occurrence Handle1:CAS:528:DC%2BD3sXit1Glsr8%3D
L. Vincent J. Varet J. Y. Pille H. Bompais P. Opolon A. Maksimenko C. Malvy M. Mirshahi H. Lu J. P. Vannier C. Soria H. Li (2003) ArticleTitleEfficacy of dendrimer-mediated angiostatin and TIMP-2 gene delivery on inhibition of tumor growth and angiogenesis: in vitro and in vivo studies Int. J. Cancer. 105 419–429 Occurrence Handle12704680 Occurrence Handle1:CAS:528:DC%2BD3sXktlWit74%3D Occurrence Handle10.1002/ijc.11105
P. Wetering ParticleVan de J. Y. Cherng H. Talsma W. E. Hennink (1997) ArticleTitleRelation between transfection efficiency and cytotoxicity of poly(2-(dimethylamino)ethyl methacrylate)/plasmid complexes J. Control. Release 49 59–69 Occurrence Handle10.1016/S0168-3659(97)00059-X
A. El-Aneed (2004) ArticleTitleAn overview of current delivery systems in cancer gene therapy J. Control. Release 94 1–14 Occurrence Handle14684267 Occurrence Handle1:CAS:528:DC%2BD3sXpslCmu70%3D Occurrence Handle10.1016/j.jconrel.2003.09.013
C. Chavany T. Saison-Behmoaras T. Doan ParticleLe F. Puisieux P. Couvreur C. Hélène (1994) ArticleTitleAdsorption of oligonucleotides onto polyisohexylcyanoacrylate nanoparticles protects them against nucleases and increase their cellular uptake Pharm. Res. 11 1370–1378 Occurrence Handle7816773 Occurrence Handle1:CAS:528:DyaK2cXmtFarsrs%3D Occurrence Handle10.1023/A:1018923301967
G. Schwab C. Chavany I. Duroux G. Goubin J. Lebeau C. Hélène T. Saison-Behmoaras (1994) ArticleTitleAntisense oligonucleotides adsorbed to polyalkylcyanoacrylate nanoparticles specifically inhibit mutated Ha-ras-mediated cell proliferation and tumorigenicity in nude mice Proc. Natl. Acad. Sci. USA 91 10460–10464 Occurrence Handle7937975 Occurrence Handle1:CAS:528:DyaK2MXhslelsr0%3D Occurrence Handle10.1073/pnas.91.22.10460
L. Tondelli A. Ricca M. Laus M. Lelli G. Citro (1998) ArticleTitleHighly efficient cellular uptake of c-myb antisense oligonucleotides through specifically designed polymeric nanospheres Nucleic Acids Res. 26 5425–5431 Occurrence Handle9826768 Occurrence Handle1:CAS:528:DyaK1MXis1Knsw%3D%3D Occurrence Handle10.1093/nar/26.23.5425
A. R. Thierry A. Rahman A. Dritschilo (1993) ArticleTitleOvercoming multidrug resistance in human tumor cells using free and liposomally encapsulated antisense oligodeoxynucleotides Biochem. Biophys. Res. Commun. 190 952–960 Occurrence Handle8094959 Occurrence Handle1:CAS:528:DyaK3sXktFGhsb0%3D Occurrence Handle10.1006/bbrc.1993.1142
S. Vinogradov E. Batrakova A. Kabanov (1999) ArticleTitlePoly(ethylene glycol)–polyethyleneimine NanoGel TM particles: novel drug delivery systems for antisense oligonucleotides Colloids Surf., B Biointerfaces 16 291–304 Occurrence Handle1:CAS:528:DyaK1MXnvFylu7Y%3D Occurrence Handle10.1016/S0927-7765(99)00080-6
W. A. May M. L. Gishizky S. L. Lessnick L. B. Lunsford B. C. Lewis O. Delattre J. Zucman G. Thomas C. T. Dennt (1993) ArticleTitleEwing sarcoma 11;22 translocation produces a chimeric transcription factor that requires the DNA-binding domain encoded by FLI1 for transformation Proc. Natl. Acad. Sci. USA 90 5752–5756 Occurrence Handle8516324 Occurrence Handle1:CAS:528:DyaK3sXltFCmsbw%3D Occurrence Handle10.1073/pnas.90.12.5752
K. Tanaka T. Iwakuma K. Harimaya H. Sato Y. Iwamoto (1997) ArticleTitleEWS-Fli1 antisense oligodeoxynucleotide inhibits proliferation of human Ewing's sarcoma and primitive neuroectodermal tumor cells J. Clin. Invest. 99 239–247 Occurrence Handle9005992 Occurrence Handle1:CAS:528:DyaK2sXntVOjug%3D%3D Occurrence Handle10.1172/JCI119152
G. Lambert J. R. Bertrand E. Fattal F. Subra H. Pinto-Alphandary C. Malvy C. Auclair P. Couvreur (2000) ArticleTitleEWS Fli-1 antisense nanocapsules inhibits Ewing sarcoma-related tumor in mice Biochem. Biophys. Res. Commun. 279 401–406 Occurrence Handle11118299 Occurrence Handle1:CAS:528:DC%2BD3cXovVCntL8%3D Occurrence Handle10.1006/bbrc.2000.3963
A. Maksimenko C. Malvy G. Lambert J. R. Bertrand E. Fattal J. Maccario P. Couvreur (2003) ArticleTitleOligonucleotides targeted against a junction oncogene are made efficient by nanotechnologies Pharm. Res. 20 1565–1567 Occurrence Handle14620508 Occurrence Handle1:CAS:528:DC%2BD3sXotFClsr0%3D Occurrence Handle10.1023/A:1026122914852
N. Toub C. Angiari D. Eboué E. Fattal J. P. Tenu T. Doan ParticleLe P. Couvreur (2005) ArticleTitleCellular fate of oligonucleotides when delivered by nanocapsules of poly(isobutylcyanoacrylate) J. Control. Release 106 209–213 Occurrence Handle15951045 Occurrence Handle1:CAS:528:DC%2BD2MXntlShsr8%3D Occurrence Handle10.1016/j.jconrel.2005.03.029
Z. Hassani G. F. Lemkine P. Erbacher K. Palmier G. Alfama C. Giovannangeli J. P. Behr B. A. Demeneix (2005) ArticleTitleLipid-mediated siRNA delivery down-regulates exogenous gene expression in the mouse brain at picomolar levels J. Gene Med. 7 198–207 Occurrence Handle15515135 Occurrence Handle1:CAS:528:DC%2BD2MXis1Kisrg%3D Occurrence Handle10.1002/jgm.659
Y. Zhang Y. F. Zhang J. Bryant A. Charles R. J. Boado W. M. Pardridge (2004) ArticleTitleIntravenous RNA interference gene therapy targeting the human epidermal growth factor receptor prolongs survival in intracranial brain cancer Clin. Cancer Res. 10 3667–3677 Occurrence Handle15173073 Occurrence Handle1:CAS:528:DC%2BD2cXksVKnsbg%3D Occurrence Handle10.1158/1078-0432.CCR-03-0740
World Health Organisation. Number of Confirmed Cases of Poliomyelitis 2002–2005 (as of 12 September 2005), http://www.emro.who.int/polio/ (accessed 16 September 2005), part of http://www.who.int (accessed 16 September 2005).
World Health Organisation. Smallpox, http://www.who.int/topics/smallpox/en/ (accessed 16 September 2005), part of http://www.who.int (accessed 16 September 2005).
S. Maesaki (2002) ArticleTitleDrug delivery system of anti-fungal and parasitic agents Curr. Pharm. Des. 8 433–440 Occurrence Handle12069380 Occurrence Handle1:CAS:528:DC%2BD38Xis1Omtrk%3D Occurrence Handle10.2174/1381612023395916
B. Dupont (2002) ArticleTitleOverview of the lipid formulations of amphothericin B J. Antimicrob. Chemother. 49 31–36 Occurrence Handle11801578 Occurrence Handle1:CAS:528:DC%2BD38XhsFChtbw%3D Occurrence Handle10.1093/jac/49.1.31
O. Ringden (2002) ArticleTitleTen years' experience with liposomal amphotericin B in transplant recipients at Huddinge University Hospital J. Antimicrob. Chemother. 49 51–55 Occurrence Handle11801582 Occurrence Handle1:CAS:528:DC%2BD38XhsFChtbg%3D
S. L. Croft G. H. Coombs (2003) ArticleTitleLeishmaniasis-current chemotherapy and recent advances in the search for novel drugs Trends Parasitol. 19 502–508 Occurrence Handle14580961 Occurrence Handle1:CAS:528:DC%2BD3sXosVyisL0%3D Occurrence Handle10.1016/j.pt.2003.09.008
A. W. K. Ng K. M. Wasan (2003) ArticleTitleDevelopment of liposomal polyene antibiotics: an historical perspective J. Pharm. Pharm. Sci. 6 67–83 Occurrence Handle12753730 Occurrence Handle1:CAS:528:DC%2BD3sXjvVGhsbk%3D
W. J. Gibbs R. H. Drew J. R. Perfect (2005) ArticleTitleLiposomal amphotericin B: clinical experience and perspectives Expert Rev. Anti-infect. Ther. 3 167–181 Occurrence Handle15918775 Occurrence Handle1:CAS:528:DC%2BD2MXjt1ymurg%3D Occurrence Handle10.1586/14787210.3.2.167
M. Owais G. C. Varshney A. Choudhury S. Chandra C. M. Gupta (1995) ArticleTitleChloroquine encapsulated in malaria-infected erythrocyte-specific antibody-bearing liposomes effectively controls chloroquine-resistant Plasmodium berghei infections in mice Antimicrob. Agents. Chemother. 39 180–184 Occurrence Handle7695303 Occurrence Handle1:CAS:528:DyaK2MXislKksbw%3D
J. P. Adler-Moore R. T. Proffitt (1993) ArticleTitleDevelopment, characterization, efficacy and mode of action of Ambisome®, a unilamellar liposome formulation of amphotericin B J. Liposome Res. 3 429–450 Occurrence Handle1:CAS:528:DyaK2cXit1Klsrk%3D
H. W. Murray (2004) ArticleTitleProgress in the treatment of a neglected infectious disease: visceral leishmaniasis Expert Rev. Anti-infect. Ther. 2 279–292 Occurrence Handle15482193 Occurrence Handle1:CAS:528:DC%2BD2cXislyqsr4%3D Occurrence Handle10.1586/14787210.2.2.279
H. W. Murray (2004) ArticleTitleTreatment of visceral leishmaniasis in 2004 Am. J. Trop. Med. Hyg. 71 787–794 Occurrence Handle15642973
M. Larabi V. Yardley P. M. Loiseau M. Appel P. Legrand A. Gulik C. Boris S. Croft G. Barratt (2003) ArticleTitleToxicity and antileishmanial activity of a new stable lipid suspension of amphothericin B Antimicrob. Agents Chemother. 47 3774–3779 Occurrence Handle14638481 Occurrence Handle1:CAS:528:DC%2BD3sXpsV2ntbw%3D Occurrence Handle10.1128/AAC.47.12.3774-3779.2003
M. K. Basu S. Lala (2004) ArticleTitleMacrophage specific drug delivery in experimental leishmaniasis Curr. Mol. Med. 4 681–689 Occurrence Handle15357216 Occurrence Handle1:CAS:528:DC%2BD2cXmvVKmt70%3D Occurrence Handle10.2174/1566524043360186
P. Legrand G. Barratt V. Mosqueira H. Fessi J. P. Devissaguet (1999) ArticleTitlePolymeric nanocapsules as drug delivery systems: a review Sci. Tech. Pharm. 9 411–418 Occurrence Handle1:CAS:528:DC%2BD3cXjsF2jsg%3D%3D
R. Gaspar V. Preat F. R. Opperdoes M. Rolland (1992) ArticleTitleMacrophage activation by polymeric nanoparticles of polyalkylcyanoacrylates: activity against intracellular Leishmania donovani associated with hydrogen peroxide production Pharm. Res. 9 782–787 Occurrence Handle1409361 Occurrence Handle1:CAS:528:DyaK38Xktlemuro%3D Occurrence Handle10.1023/A:1015807706530
M. Fouarge M. Dewulf P. Couvreur M. Rolland H. Vranckx (1989) ArticleTitleDevelopment of dehydroemetine nanoparticles for the treatment of visceral leishmaniasis J. Microencapsul. 6 29–34 Occurrence Handle2565955 Occurrence Handle1:CAS:528:DyaL1MXhs1Sgsb4%3D
M. S. Espuelas P. Legrand M. A. Campanero M. Appel M. Chéron C. Gamazo G. Barratt J. M. Irache (2003) ArticleTitlePolymeric carriers for amphotericin B: in vitro activity, toxicity and therapeutic efficacy against systemic candidiasis in neutropenic mice J. Antimicrob. Chemother. 52 419–427 Occurrence Handle12888593 Occurrence Handle1:CAS:528:DC%2BD3sXnt1Kjt7Y%3D Occurrence Handle10.1093/jac/dkg351
R. Tyagi S. Lala A. K. Verma A. K. Nandy S. B. Mahato A. Maitra M. K. Basu (2005) ArticleTitleTargeted delivery of arjunglucoside I using surface hydrophilic and hydrophobic nanocarriers to combat experimental leishmaniasis J. Drug Target. 13 161–171 Occurrence Handle16036304 Occurrence Handle1:CAS:528:DC%2BD2MXjvFajsb0%3D
V. C. F. Mosqueira P. M. Loiseau C. Bories P. Legrand J. P. Devissaguet G. Barratt (2004) ArticleTitleEfficacy and pharmacokinetics of intravenous nanocapsule formulations of halofantrine in Plasmodium berghei-infected mice Antimicrob. Agents Chemother. 48 1222–1228 Occurrence Handle15047523 Occurrence Handle1:CAS:528:DC%2BD2cXjtVKqsr4%3D Occurrence Handle10.1128/AAC.48.4.1222-1228.2004
I. A. Bakker-Woudenberg (2002) ArticleTitleLong-circulating sterically stabilized liposomes as carriers of agents for treatment of infection or for imaging infectious foci Int. J. Antimicrob. Agents 19 299–311 Occurrence Handle11978501 Occurrence Handle1:CAS:528:DC%2BD38XjtVeisL0%3D Occurrence Handle10.1016/S0924-8579(02)00021-3
H. Pinto-Alphandary A. Andremont P. Couvreur (2000) ArticleTitleTargeted delivery of antibiotics using liposomes and nanoparticles: research and applications Int. J. Antimicrob. Agents 13 155–168 Occurrence Handle10724019 Occurrence Handle1:CAS:528:DyaK1MXns1Whur0%3D Occurrence Handle10.1016/S0924-8579(99)00121-1
R. Schiffelers G. Storm I. Bakker-Woudenberg (2001) ArticleTitleLiposome-encapsulated aminoglycosides in pre-clinical and clinical studies J. Antimicrob. Chemother. 48 333–344 Occurrence Handle11532996 Occurrence Handle1:CAS:528:DC%2BD3MXntlSgtL8%3D Occurrence Handle10.1093/jac/48.3.333
G. Barratt (2004) ArticleTitleColloidal drug carriers: achievements and perspectives Cell. Mol. Life Sci. 60 21–37 Occurrence Handle10.1007/s000180300002
R. M. Fielding R. O. Lewis L. Moon-McDermott (1998) ArticleTitleAltered tissue distribution and elimination of Amikacin encapsulated in unilamellar, low clearance liposomes (Mikasome®) Pharm. Res. 15 1775–1781 Occurrence Handle9834002 Occurrence Handle1:CAS:528:DyaK1cXnsFSns7Y%3D Occurrence Handle10.1023/A:1011925132473
R. M. Fielding L. Moon-McDermott R. O. Lewis M. J. Horner (1999) ArticleTitlePharmacokinetics and urinary excretion of amikacin in low-clearance unilamellar liposomes after a single or repeated intravenous administration in the rhesus monkey Antimicrob. Agents Chemother. 43 503–509 Occurrence Handle10049258 Occurrence Handle1:CAS:528:DyaK1MXhsF2htLo%3D Occurrence Handle10.1093/jac/43.4.503
P. R. Donald F. A. Sirgel A. Venter E. Smit D. P. Parkin B. W. Wal ParticleVan de D. A. Mitchison (2001) ArticleTitleThe early bactericidal activity of a low-clearance liposomal amikacin in pulmonary tuberculosis J. Antimicrob. Chemother. 48 877–880 Occurrence Handle11733472 Occurrence Handle1:CAS:528:DC%2BD38Xjt1eitA%3D%3D Occurrence Handle10.1093/jac/48.6.877
E. Fattal M. Youssef P. Couvreur A. Andremont (1989) ArticleTitleTreatment of experimental salmonellosis in mice with ampicillin-bound nanoparticles Antimicrob. Agents Chemother. 33 1540–1543 Occurrence Handle2684009 Occurrence Handle1:CAS:528:DyaL1MXlvVSmurk%3D
E. Fattal J. Rojas M. Youssef P. Couvreur A. Andremont (1991) ArticleTitleLiposome-entrapped ampicillin in the treatment of experimental murine listeriosis and salmonellosis Antimicrob. Agents Chemother. 35 770–772 Occurrence Handle2069386 Occurrence Handle1:CAS:528:DyaK3MXitFCgsr8%3D
E. Fattal O. Balland H. Alphandary S. Pecquet F. Puisieux P. Couvreur A. Andremont (1993) Colloidal carriers of antibiotics as an alternative approach for the treatment of intracellular infections D. Raoult (Eds) Antimicrobial Agents and Intracellular Pathogens CRC Press Boca Raton, FL 63–72
M. Yousseff E. Fattal M. J. Alonso L. Roblot-Treupel J. Sauzières C. Tancrède A. Omnes P. Couvreur A. Andremont (1988) ArticleTitleEffectiveness of nanoparticle-bound ampicillin in the treatment of Listeria monocytogenes infection in athymic nude mice Antimicrob. Agents Chemother. 32 1204–1207
M. E. Page-Clisson H. Pinto-Alphandary E. Chachaty P. Couvreur A. Andremont (1998) ArticleTitleDrug targeting by polyalkylcyanoacrylate is not efficient against persistent Salmonella Pharm. Res. 15 542–547
Y. Zhang (2005) ArticleTitleThe magic bullets and tuberculosis targets Annu. Rev. Pharmacol. Toxicol. 45 529–564 Occurrence Handle15822188 Occurrence Handle1:CAS:528:DC%2BD2MXisVWjtLg%3D Occurrence Handle10.1146/annurev.pharmtox.45.120403.100120
A. I. Vitas R. Diaz C. Gamazo (1996) ArticleTitleEffect on composition and method of preparation of liposomes on their stability and interaction with murine monocytes infected with Brucella abortus Antimicrob. Agents Chemother. 40 146–151 Occurrence Handle8787896 Occurrence Handle1:CAS:528:DyaK28XhvFOitQ%3D%3D
A. Engel S. Kumar Chatterjee A. Al-Arifi D. Riemann J. Laugner P. Nuhn (2003) ArticleTitleInfluence of spacer length in interaction of mannosylated liposomes with human phagocytic cells Pharm. Res. 20 51–57 Occurrence Handle12608536 Occurrence Handle1:CAS:528:DC%2BD3sXoslKhsA%3D%3D Occurrence Handle10.1023/A:1022294624256
K. E. Anderson L. A. Eliot B. R. Stevenson J. A. Rogers (2001) ArticleTitleFormulation and evaluation of a folic acid receptor-targeted oral vancomycin liposomal dosage form Pharm. Res. 18 316–322 Occurrence Handle11442271 Occurrence Handle1:CAS:528:DC%2BD3MXltVSksbo%3D Occurrence Handle10.1023/A:1011002913601
C. I. Price J. W. Horton C. R. Baxter (1994) ArticleTitleLiposome encapsulation: a method for enhancing the effectiveness of local antibiotics Surgery 115 480–487 Occurrence Handle8165539 Occurrence Handle1:STN:280:DyaK2c3hvVOqsw%3D%3D
N. M. Sanderson M. N. Jones (1996) ArticleTitleEncapsulation of vancomycin and gentamicin within cationic liposomes for inhibition of growth of Staphylococcus epidermidis J. Drug Target. 4 181–189 Occurrence Handle8959490 Occurrence Handle1:CAS:528:DyaK28XntVGnt7c%3D
J. Frucht-Perry K. K. Assil E. Ziegler H. Douglas S. I. Brown D. J. Schanzlin R. N. Weinreb (1992) ArticleTitleFibrin-enmeshed tobramycin liposomes: single application topical therapy of Pseudomonas keratitis Cornea 11 393–397 Occurrence Handle1424666 Occurrence Handle1:STN:280:DyaK3s%2FkvVSjsA%3D%3D
J. Conley H. Yang T. Wilson K. Blasetti V. Ninno ParticleDi G. Schnell J. Park Wong (1997) ArticleTitleAerosol delivery of liposome-encapsulated ciprofloxacin: aerosol characterization and efficacy against Francisella tularensis infection in mice Antimicrob. Agents Chemother. 41 1288–1292 Occurrence Handle9174185 Occurrence Handle1:CAS:528:DyaK2sXjsFCgtL8%3D
J. P. Wong H. Yang K. L. Blasetti G. Schnell J. Conley L. N. Schofield (2003) ArticleTitleLiposome delivery of ciprofloxacin against intracellular Francisella tularensis infection J. Control. Release 92 265–273 Occurrence Handle14568408 Occurrence Handle1:CAS:528:DC%2BD3sXot1SrsLo%3D Occurrence Handle10.1016/S0168-3659(03)00358-4
M. A. Rauschmann T. A. Wichelhous V. Stirnal E. Dingeldein L. Zichner R. Schnettle V. Alt (2005) ArticleTitleNanocrystalline hydroxyapatite and calcium sulphate as biodegradable composite carrier material for local delivery of antibiotics in bone infections Biomaterials 26 2677–2684 Occurrence Handle15585271 Occurrence Handle1:CAS:528:DC%2BD2cXhtVChsrrK Occurrence Handle10.1016/j.biomaterials.2004.06.045
D. Jikia N. Chkhaidze E. Imedashvili I. Mgaloblishvili G. Tsitlanadze R. Katsarava J. Glenn Morris A. Sulakvelidze (2005) ArticleTitleThe use if a novel biodegradable preparation capable of the sustained release of bacteriophages and ciprofloxacin, in the complex treatment of multidrug-resistant Staphylococcus aureus-infection local radiation injuries caused by exposure to Sr 90 Clin. Exp. Dermatol. 30 23–26 Occurrence Handle15663496 Occurrence Handle1:STN:280:DC%2BD2M%2Fjs12mtQ%3D%3D Occurrence Handle10.1111/j.1365-2230.2004.01600.x
J. Wang B. Hu M. Xu Q. Yan S. Liu X. Zhu Z. Sun D. Tao L. Ding E. Reed J. Gong Q. Q. Li J. Hu (2006) ArticleTitleTherapeutic effectiveness of bacteriophages in the rescue of mice with extended spectrum beta-lactamase-producing Escherichia coli bacteremia Int. J. Mol. Med. 17 347–355 Occurrence Handle16391836
J. Wang B. Hu M. Xu Q. Yan S. Liu X. Zhu Z. Sun E. Reed L. Ding J. Gong Q. Q. Li J. Hu (2006) ArticleTitleUse of bacteriophage in the treatment of experimental animal bacteremia from imipenem-resistant Pseudomonas aeruginosa Int. J. Mol. Med. 17 309–317 Occurrence Handle16391831
D. A. Putnam (1996) ArticleTitleAntisense strategies and therapeutic applications Am. J. Health-Syst. Pharm. 52 151–160
N. Duzgunes E. Pretzer S. Simoes V. Slepushkin K. Konopka D. Flasher M. C. Pedroso de Lima (1999) ArticleTitleLiposome-mediated delivery of antiviral agents to human immunodeficiency virus-infected cells Mol. Membr. Biol. 16 111–118 Occurrence Handle10332745 Occurrence Handle1:CAS:528:DyaK1MXis1Ggsr4%3D Occurrence Handle10.1080/096876899294832
C. Martinand-Mari B. Lebleu I. Robbins (2003) ArticleTitleOligonucleotide-based strategies to inhibit human hepatitis C virus Oligonucleotides 13 348–539 Occurrence Handle10.1089/154545703322860834 Occurrence Handle1:CAS:528:DC%2BD2cXhs12kurs%3D
V. Nair (2003) ArticleTitleNovel inhibitors of HIV integrase: the discovery of potential anti-HIV therapeutic agents Curr. Pharm. Des. 9 2553–2565 Occurrence Handle14529542 Occurrence Handle1:CAS:528:DC%2BD3sXpsVCktL0%3D Occurrence Handle10.2174/1381612033453703
K. Maggon S. Barik (2004) ArticleTitleNew drugs and treatment for respiratory syncytial virus Rev. Med. Virol. 14 149–168 Occurrence Handle15124232 Occurrence Handle1:CAS:528:DC%2BD2cXltFOlt7o%3D Occurrence Handle10.1002/rmv.423
J. M. Irache M. Merodio A. Arnedo M. A. Camapanero M. Mirchahi S. Espuelas (2005) ArticleTitleAlbumin nanoparticles for the intravitreal delivery of anticytomegaloviral drugs Mini Rev. Med. Chem. 5 293–305 Occurrence Handle15777263 Occurrence Handle1:CAS:528:DC%2BD2MXhvVCgt74%3D
M. Markosian R. M. Hyde (2005) ArticleTitleOligonucleotides and polyribonucleotides: a review of antiviral activity Antivir. Chem. Chemother. 16 91–102 Occurrence Handle15889532 Occurrence Handle1:CAS:528:DC%2BD2MXktlanu78%3D
N. Duzgunes S. Simoes V. Slepushkin E. Pretzer E. Clerq ParticleDe V. P. Antao M. L. Collins M. C. Pedroso de Lima (2001) ArticleTitleEnhanced inhibition of HIV-1 replication in macrophages by antisense oligonucleotides, ribozymes and acyclic nucleoside phosphonate analogs delivered in pH sensitive liposomes Nucleosides Nucleotides Nucleic Acids 20 515–523 Occurrence Handle11563068 Occurrence Handle1:CAS:528:DC%2BD3MXmslCqs7Y%3D Occurrence Handle10.1081/NCN-100002327
A. M. Harandi (2004) ArticleTitleThe potential of immunostimulatory CpG DNA for inducing immunity against genital herpes: opportunities and challenges J. Clin. Virol. 30 207–210 Occurrence Handle15135735 Occurrence Handle1:CAS:528:DC%2BD2cXjvVanur8%3D
G. K. Mutwiri A. K. Nichano S. Babiuk L. A. Babiuk (2004) ArticleTitleStrategies for enhancing the immunostimulatory effects of CpG oligodeoxynucleotides J. Control. Release 97 1–17 Occurrence Handle15147800 Occurrence Handle1:CAS:528:DC%2BD2cXjvFOntr8%3D Occurrence Handle10.1016/j.jconrel.2004.02.022
D. Trabattoni A. Clivio D. H. Bray L. Bhagat S. Beltrami G. Maffeis R. Cesana P. Lowry F. Lissoni E. R. Kandimalla T. Sullivan S. Agrawal R. Bartholomew M. Clerici (2006) ArticleTitleImmunization with gp120-depleted whole killed HIV immunogen and a second-generation CpG DNA elicits strong HIV-specific responses in mice Vaccine 24 1470–1477 Occurrence Handle16221513 Occurrence Handle1:CAS:528:DC%2BD28Xhs1Smt7c%3D Occurrence Handle10.1016/j.vaccine.2005.05.047
A. Bochot P. Couvreur E. Fattal (2000) ArticleTitleIntravitreal administration of antisense oligonucleotides: potential of liposomal delivery Prog. Retin. Eye Res. 19 131–147 Occurrence Handle10674705 Occurrence Handle1:CAS:528:DC%2BD3cXhtFaruro%3D Occurrence Handle10.1016/S1350-9462(99)00014-2
A. Arnedo J. M. Irache M. Merodio M. S. Espuelas Millan (2004) ArticleTitleAlbumin nanoparticles improved the stability, nuclear accumulation and anticytomegaloviral activity of a phosphodiester oligonucleotide J. Control. Release 94 217–227 Occurrence Handle14684285 Occurrence Handle1:CAS:528:DC%2BD3sXpslClsbY%3D Occurrence Handle10.1016/j.jconrel.2003.10.009
A. Bochot E. Fattal V. Boutet J. R. Deverre J. C. Jeanny H. Chacun P. Couvreur (2002) ArticleTitleIntravitreal delivery of oligonucleotides by sterically stabilized liposomes Investig. Ophtalmol. Vis. Sci. 43 253–259
E. Fattal G. Rosa ParticleDe A. Bochot (2004) ArticleTitleGel and solid matrix systems for the controlled delivery of drug carrier-associated nucleic acids Int. J. Pharm. 277 25–30 Occurrence Handle15158966 Occurrence Handle1:CAS:528:DC%2BD2cXktFOisL0%3D Occurrence Handle10.1016/j.ijpharm.2003.01.002
F. Shi D. Hoekstra (2004) ArticleTitleEffective intracellular delivery of oligonucleotides in order to make sense of antisense J. Control. Release 97 189–209 Occurrence Handle15196747 Occurrence Handle1:CAS:528:DC%2BD2cXkslKmtLY%3D Occurrence Handle10.1016/j.jconrel.2004.03.016
C. Ropert M. Lavigno C. Dubernet P. Couvreur C. Malvy (1992) ArticleTitleOligonucleotides encapsulated in pH-sensitive liposomes are efficient toward Friend retrovirus Biochem. Biophys. Res. Commun. 183 879–885 Occurrence Handle1550594 Occurrence Handle1:CAS:528:DyaK38XitVSqtbs%3D Occurrence Handle10.1016/0006-291X(92)90565-3
C. Ropert C. Malvy P. Couvreur (1993) ArticleTitleInhibition of the Friend retrovirus by antisense oligonucleotides encapsulated in liposomes: mechanism of action Pharm. Res. 10 1427–1433 Occurrence Handle8272403 Occurrence Handle1:CAS:528:DyaK3sXmslyntLc%3D Occurrence Handle10.1023/A:1018910922633
C. Ropert Z. Mishal SuffixJr. J. M. Rodrigues C. Malvy P. Couvreur (1996) ArticleTitleRetrovirus budding may contribute a port of entry for drug carriers Biochim. Biophys. Acta 1310 53–59 Occurrence Handle9244175 Occurrence Handle10.1016/0167-4889(95)00140-9
M. Berton P. Turelli D. Trono C. A. Stein E. Allemann R. Gurny (2001) ArticleTitleInhibition of HIV-1 in cell culture by oligonucleotide-loaded nanoparticles Pharm. Res. 18 1096–1101 Occurrence Handle11587479 Occurrence Handle1:CAS:528:DC%2BD3MXnt1ektrk%3D Occurrence Handle10.1023/A:1010962507273
A. Zimmer (1999) ArticleTitleAntisense oligonucleotides delivery with polyhexylcyanoacrylate nanoparticles as carriers Methods 18 286–295 Occurrence Handle10454987 Occurrence Handle1:CAS:528:DyaK1MXltFKkurs%3D Occurrence Handle10.1006/meth.1999.0786
G. Lambert E. Fattal P. Couvreur (2001) ArticleTitleNanoparticulate systems for the delivery of antisense oligonucleotides Adv. Drug Deliv. Rev. 47 99–112 Occurrence Handle11251248 Occurrence Handle1:CAS:528:DC%2BD3MXhvVajsrc%3D Occurrence Handle10.1016/S0169-409X(00)00116-2
V. Vogel D. Lochmann J. Weyermann G. Mayer C. Tziatzios J. A. Broek ParticleVan den W. Haase D. Wouters U. S. Schubert J. Kreuter A. Zimmer D. Schubert (2005) ArticleTitleOligonucleotide–protamine–albumin nanoparticles: preparation, physical properties, and intracellular distribution J. Control. Release 103 99–111 Occurrence Handle15710504 Occurrence Handle1:CAS:528:DC%2BD2MXhtlequrs%3D Occurrence Handle10.1016/j.jconrel.2004.11.029
Q. Hu C. R. Shew M. B. Bally T. D. Madden (2001) ArticleTitleProgrammable fusogenic vesicles for intracellular delivery of antisense oligodeoxynucleotides: enhanced cellular uptake and biological effects Biochim. Biophys. Acta 1514 1–13 Occurrence Handle11513800 Occurrence Handle1:CAS:528:DC%2BD3MXmtFWjt7k%3D Occurrence Handle10.1016/S0005-2736(01)00294-2
J. Kunizawa T. Masuda K. Katayama T. Yoshikawa Y. Tsutsumi M. Akashi T. Mayumi S. Nakagawa (2005) ArticleTitleFusogenic liposome delivers encapsulated nanoparticles for cytosolic controlled gene release J. Control. Release 105 344–353 Occurrence Handle10.1016/j.jconrel.2005.03.020 Occurrence Handle1:CAS:528:DC%2BD2MXlvVyrtbw%3D
A. Dembri M. J. Montisci J. C. Gantier H. Chacun G. Ponchel (2001) ArticleTitleTargeting of 3′-azido 3′-deoxythymidine (AZT)-loaded poly(isohexylcyanoacrylate) nanospheres to the gastrointestinal mucosa and associated lymphoid tissues Pharm. Res. 18 467–473 Occurrence Handle11451033 Occurrence Handle1:CAS:528:DC%2BD3MXkvFCnsrY%3D Occurrence Handle10.1023/A:1011050209986
H. Boudad P. Legrand M. Appel M. H. Coconier G. Ponchel (2001) ArticleTitleFormulation and cytotoxicity of combined cyclodextrin poly(alkylcyanoacrylate) nanoparticles on Caco-2 cells monolayers intended for oral administration of saquinavir STP Pharm. Sci. 11 369–375 Occurrence Handle1:CAS:528:DC%2BD38XovVKltw%3D%3D
A. R. Bender H. Briesen ParticleVon J. Kreuter I. B. Duncan H. Rubasmen-Waigmann (1996) ArticleTitleEfficiency of nanoparticles as a carrier system for antiviral agents in human immunodeficiency virus-infected human monocytes/macrophages in vitro Antimicrob. Agents Chemother. 40 1467–1471 Occurrence Handle8726020 Occurrence Handle1:CAS:528:DyaK28XjtlWmtbw%3D
F. Jaeghere ParticleDe E. Allemann F. Kubel B. Galli R. Cozens E. Doelker R. Gurny (2000) ArticleTitleOral bioavailability of a poorly water soluble HIV-1 protease inhibitor incorporated into pH-sensitive particles: effect of the particle size and nutritional state J. Control. Release 68 291–298 Occurrence Handle10925137 Occurrence Handle10.1016/S0168-3659(00)00272-8
M. Meridio J. M. Irache F. Valamanesh M. Mirshahi (2002) ArticleTitleOcular disposition and tolerance of ganciclovir-loaded albumin nanoparticles after intravitreal injection in rats Biomaterials 23 1587–1594 Occurrence Handle10.1016/S0142-9612(01)00284-8
M. Fresta G. Fontana C. Bucolo G. Cavallo G. Giammona G. Puglisi (2001) ArticleTitleOcular tolerability and in vivo bioavailability of poly(ethylene glycol) (PEG)-coated polyethyl-2-cyanoacrylate nanosphere-encapsulated acyclovir J. Pharm. Sci. 9 288–297 Occurrence Handle10.1002/1520-6017(200103)90:3<288::AID-JPS4>3.0.CO;2-5
S. C. Sookoian (2003) ArticleTitleNew therapies on the horizon for hepatitis C Ann. Hepatol. 2 164–170 Occurrence Handle15115955
G. V. Papatheodorodis E. Cholongitas (2004) ArticleTitleChronic hepatitis C and no response to antiviral therapy: potential current and future therapeutic options J. Viral Hepatitis 11 287–296 Occurrence Handle10.1111/j.1365-2893.2004.00522.x
M. L. Shiffman (2004) ArticleTitleRetreatment of patients who do not respond to initial therapy for chronic hepatitis C Clevel. Clin. J. Med. 71 S13–S16 Occurrence Handle10.3949/ccjm.71.Suppl_3.S13
M. Singh D. T. O'Hagan (2002) ArticleTitleRecent advances in vaccine adjuvants Pharm. Res. 19 715–728 Occurrence Handle12134940 Occurrence Handle1:CAS:528:DC%2BD38XltVSgsLs%3D Occurrence Handle10.1023/A:1016104910582
J. A. Berzofsky J. D. Ahlers J. Janik J. Morris S. Oh M. Tarabe I. M. Belyakov (2004) ArticleTitleProgress on new vaccine strategies against chronic viral infections J. Clin. Invest. 114 450–462 Occurrence Handle15314679 Occurrence Handle1:CAS:528:DC%2BD2cXmvVemu70%3D Occurrence Handle10.1172/JCI200422674
D. T. O'Hagan R. Rappuoli (2004) ArticleTitleNovel approaches to vaccine delivery Pharm. Res. 21 1519–1530 Occurrence Handle15497674 Occurrence Handle10.1023/B:PHAM.0000041443.17935.33
M. Vajdy I. Srivastava J. Polo J. Donnelly D. O'Hagan M. Singh (2004) ArticleTitleMucosal adjuvants and delivery systems for protein-,DNA- and RNA-based vaccines Immunol. Cell Biol. 82 616–627 Occurrence Handle10.1111/j.1440-1711.2004.01288.x Occurrence Handle1:CAS:528:DC%2BD2cXhtFakur%2FP
J. Kreuter (1995) ArticleTitleNanoparticles as adjuvants for vaccines Pharm. Biotechnol. 6 463–472 Occurrence Handle7551231 Occurrence Handle1:CAS:528:DyaK2MXpsFGrsrw%3D
Z. H. Jiang R. R. Koganty (2003) ArticleTitleSynthetic vaccines: the role of adjuvants in immune targeting Curr. Med. Chem. 10 1423–1439 Occurrence Handle12871139 Occurrence Handle1:CAS:528:DC%2BD3sXls1Wrtbc%3D Occurrence Handle10.2174/0929867033457340
C. Moser I. C. Metcalfe J. F. Viret (2003) ArticleTitleVirosomal adjuvanted antigen delivery systems Expert Rev. Vaccines 2 189–196 Occurrence Handle12899570 Occurrence Handle1:CAS:528:DC%2BD3sXjsVOksL4%3D Occurrence Handle10.1586/14760584.2.2.189
L. Leserman (2004) ArticleTitleLiposomes as protein carriers in immunology J. Liposome Res. 14 175–189 Occurrence Handle15676125 Occurrence Handle1:CAS:528:DC%2BD2cXhtVCisbjJ Occurrence Handle10.1081/LPR-200039198
M. J. Copland T. Rades N. M. Davies M. A. Baird (2005) ArticleTitleLipid based particulate formulations for the delivery of antigens Immunol. Cell Biol. 83 97–105 Occurrence Handle15748206 Occurrence Handle1:CAS:528:DC%2BD2MXjsV2qsro%3D Occurrence Handle10.1111/j.1440-1711.2005.01315.x
A. Huckriede L. Bungener T. Stegmann T. Daemen J. Medema A. M. Palache J. Wilschut (2005) ArticleTitleThe virosome concept for influenza vaccines Vaccine 23S1 S1/26–S1/38
N. Westerfeld R. Zurbriggen (2005) ArticleTitlePeptides delivered by immunostimulating reconstituted influenza virosomes J. Pept. Sci. 11 707–712 Occurrence Handle16059967 Occurrence Handle1:CAS:528:DC%2BD2MXht1ehtL%2FN Occurrence Handle10.1002/psc.700
J. Kreuter P. Speiser (1976) ArticleTitleIn vitro studies of poly(methylmethacrylate) adjuvants J. Pharm. Sci. 65 1624–1627 Occurrence Handle993993 Occurrence Handle1:CAS:528:DyaE2sXitFOgtw%3D%3D
G. Gregoriadis (1994) ArticleTitleThe immunological adjuvant and vaccine carrier properties of liposomes J. Drug Target. 2 351–356 Occurrence Handle7704478 Occurrence Handle1:CAS:528:DyaK2MXjtVChsbc%3D
J. Aucouturier L. Dupuis V. Ganne (2001) ArticleTitleAdjuvants designed for veterinary and human vaccines Vaccine 19 2666–2672 Occurrence Handle11257407 Occurrence Handle1:CAS:528:DC%2BD3MXitVOitrY%3D Occurrence Handle10.1016/S0264-410X(00)00498-9
T. Daemen L. Bungener A. Huckriede J. Wilschut (2000) ArticleTitleVirosomes as an antigen delivery system J. Liposome Res. 10 329–338 Occurrence Handle1:CAS:528:DC%2BD3MXlt1GktA%3D%3D
R. Glück I. C. Metcalfe (2002) ArticleTitleNew technology platforms in the development of vaccines for the future Vaccine 20 B10–B16 Occurrence Handle12477412 Occurrence Handle10.1016/S0264-410X(02)00513-3
S. Esposito P. Marchisio S. Bosis L. Lambertini L. Claut N. Faelli C. Bianchi G. L. Colombo N. Principi (2006) ArticleTitleClinical and economic impact of influenza vaccination on healthy children aged 2–5 years Vaccine 24 629–635 Occurrence Handle16157429 Occurrence Handle10.1016/j.vaccine.2006.03.059
R. Noad P. Roy (2003) ArticleTitleVirus-like particles as immunogens Trends Microbiol. 11 438–444 Occurrence Handle13678860 Occurrence Handle1:CAS:528:DC%2BD3sXnt1ylu70%3D Occurrence Handle10.1016/S0966-842X(03)00208-7
R. L. Garcea L. Gissmann (2004) ArticleTitleVirus-like particles as vaccines and vessels for the delivery of small molecules Curr. Opin. Biotechnol. 15 513–517 Occurrence Handle15560977 Occurrence Handle1:CAS:528:DC%2BD2cXhtVWjtrzM Occurrence Handle10.1016/j.copbio.2004.10.002
T. Storni C. Ruedl K. Schwarz R. A. Schwendener W. A. Renner M. F. Bachmann (2004) ArticleTitleNonmethylated CG motifs packaged into virus-like particles induce protective cytotoxic T cell responses in the absence of systemic side effects J. Immunol. 172 1777–1785 Occurrence Handle14734761 Occurrence Handle1:CAS:528:DC%2BD2cXptl2hsg%3D%3D
B. Morein K. F. Hu I. Abusugra (2004) ArticleTitleCurrent status and potential application of ISCOMs in veterinary medicine Adv. Drug Deliv. Rev. 56 1367–1382 Occurrence Handle15191787 Occurrence Handle1:CAS:528:DC%2BD2cXkvVCrt7g%3D Occurrence Handle10.1016/j.addr.2004.02.004
P. Hoegen ParticleVon (2001) ArticleTitleSynthetic biomimetic supra molecular Biovector™ (SMBV™) particles for nasal vaccine delivery Adv. Drug Deliv. Rev. 51 113–125 Occurrence Handle10.1016/S0169-409X(01)00175-2
A. Debin R. Kravtzoff J. Santiago ParticleVaz L. Cazales S. Sperandio K. Melber Z. Janowicz D. Betbeder M. Moynier (2002) ArticleTitleIntranasal immunization with recombinant antigens associated with new cationic particles induces strong mucosal as well as systemic antibody and CTL responses Vaccine 20 2752–2763 Occurrence Handle12034102 Occurrence Handle1:CAS:528:DC%2BD38XktVCrtbc%3D Occurrence Handle10.1016/S0264-410X(02)00191-3
B. C. Baudner O. Balland M. M. Guiliani P. Hoegen ParticleVon R. Rappuoli D. Betbeder G. Giudice ParticleDel (2002) ArticleTitleEnhancement of protective efficacy following intranasal immunization with vaccine plus a nontoxic LTK63 mutant delivered nanoparticles Infect. Immun. 70 4785–4790 Occurrence Handle12183520 Occurrence Handle1:CAS:528:DC%2BD38Xmtl2itb0%3D Occurrence Handle10.1128/IAI.70.9.4785-4790.2002
T. Jung W. Kamm A. Breitenbach K. D. Hungerer E. Hundt T. Kissel (2001) ArticleTitleTetanus toxoid loaded nanoparticles from sulfobutylated poly(vinylalcohol)-graft-poly(lactide-co-glycolide): evaluation of antibody response after oral and nasal application in mice Pharm. Res. 18 352–360 Occurrence Handle11442276 Occurrence Handle1:CAS:528:DC%2BD3MXltVSksbc%3D Occurrence Handle10.1023/A:1011063232257
M. Conacher J. Alexander J. M. Brewer (2001) ArticleTitleOral immunisation with peptide and protein antigens by formulation in lipid vesicles incorporating bile salts (bilosomes) Vaccine 19 2965–2974 Occurrence Handle11282208 Occurrence Handle1:CAS:528:DC%2BD3MXit1Wgtb0%3D Occurrence Handle10.1016/S0264-410X(00)00537-5
R. Gluck (2002) ArticleTitleIntranasal immunization against influenza J. Aerosol Med. 15 221–218 Occurrence Handle12184872 Occurrence Handle10.1089/089426802320282347
J. Holmgren C. Czerkinsky K. Erikssen A. Mharandi (2003) ArticleTitleMucosal immunisation and adjuvants: a brief overview of recent advances and challenges Vaccine 21 IssueID(Suppl 2) S89–S95 Occurrence Handle12763689 Occurrence Handle10.1016/S0264-410X(03)00206-8 Occurrence Handle1:CAS:528:DC%2BD3sXjvFWls7w%3D
J. Panyam V. Labhasetwar (2003) ArticleTitleBiodegradable nanoparticles for drug and gene delivery to cells and tissue Adv. Drug Deliv. Rev. 55 329–347 Occurrence Handle12628320 Occurrence Handle1:CAS:528:DC%2BD3sXhs1Cgurw%3D Occurrence Handle10.1016/S0169-409X(02)00228-4
M. Koping-Hoggard A. Sanchez M. J. Alonso (2005) ArticleTitleNanoparticles as carriers for nasal vaccine delivery Expert Rev. Vaccines 4 185–196 Occurrence Handle15889992 Occurrence Handle10.1586/14760584.4.2.185 Occurrence Handle1:CAS:528:DC%2BD2MXjt1yls7w%3D
A. T. Florence (1997) ArticleTitleThe oral absorption of micro- and nanoparticulates: neither exceptional nor unusual Pharm. Res. 14 259–266 Occurrence Handle9098866 Occurrence Handle1:CAS:528:DyaK2sXisVGlsro%3D Occurrence Handle10.1023/A:1012029517394
S. Mcclean F. Prosser F. Meehan D. O'Malley N. Clarke Z. Ramtoola D. Brayden (1998) ArticleTitleBinding and uptake of biodegradable poly-dl-lactide micro- and nanoparticles in intestinal epithelia Eur. J. Pharm. Sci. 6 153–163 Occurrence Handle9795038 Occurrence Handle1:CAS:528:DyaK1cXhsFejt7s%3D Occurrence Handle10.1016/S0928-0987(97)10007-0
T. Jung W. Kamm A. Breitenbach E. Kaiserling J. X. Xiao T. Kissel (2000) ArticleTitleBiodegradable nanoparticles for oral delivery of peptides: is there a role for polymers to affect mucosal uptake? Eur. J. Pharm. Biopharm. 50 147–160 Occurrence Handle10840198 Occurrence Handle1:CAS:528:DC%2BD3cXjslyisrs%3D Occurrence Handle10.1016/S0939-6411(00)00084-9
E. Fattal S. Pecquet P. Couvreur A. Andremont (2002) ArticleTitleBiodegradable microparticles for the mucosal delivery of antibacterial and dietary antigens Int. J. Pharm. 242 15–24 Occurrence Handle12176221 Occurrence Handle1:CAS:528:DC%2BD38Xmt1ygur4%3D Occurrence Handle10.1016/S0378-5173(02)00181-3
M. Shakweh M. Besnard V. Nicolas E. Fattal (2005) ArticleTitlePoly(lactide-co-glycolide) particles of different physicochemical properties and their uptake by Peyer's patches in mice Eur. J. Pharm. Biopharm. 61 1–13 Occurrence Handle16005619 Occurrence Handle1:CAS:528:DC%2BD2MXntVGjs7Y%3D Occurrence Handle10.1016/j.ejpb.2005.04.006
T. Fifis A. Gamvrellis B. Crimeen-Irwin G. A. Pietersz J. Li P. L. Mottram I. F. McKenzie M. Plebanski (2004) ArticleTitleSize-dependent immunogenicity: therapeutic and protective properties of nano-vaccines against tumors J. Immunol. 173 3148–3154 Occurrence Handle15322175 Occurrence Handle1:CAS:528:DC%2BD2cXmvVCqtrs%3D
J. F. Mann V. A. Ferro A. B. Mullen L. Tetley M. Mullen K. C. Carter J. Alexander W. H. Stimson (2004) ArticleTitleOptimisation of a lipid based oral delivery system containing A/Panama influenza haemagglutinin Vaccine 22 2425–2429 Occurrence Handle15193405 Occurrence Handle1:CAS:528:DC%2BD2cXkvVemt7w%3D Occurrence Handle10.1016/j.vaccine.2003.11.067
U. Gluck J. O. Gebbers R. Gluck (1999) ArticleTitlePhase 1 evaluation of intranasal virosomal influenza vaccine with and without Escherichia coli heat-labile toxin in adult volunteers J. Virol. 73 7780–7786 Occurrence Handle10438868 Occurrence Handle1:CAS:528:DyaK1MXltlKhur0%3D
M. Mutsch W. Zhou P. Rhodes M. Bopp R. T. Chen T. Linder C. Spyr R. Steffen (2004) ArticleTitleUse of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland N. Engl. J. Med. 350 896–903 Occurrence Handle14985487 Occurrence Handle1:CAS:528:DC%2BD2cXhsFygsbY%3D Occurrence Handle10.1056/NEJMoa030595
J. A. Berzofsky J. D. Ahlers I. M. Belyakov (2001) ArticleTitleStrategies for designing and optimizing new generation vaccines Nat. Rev. Immunol. 1 209–219 Occurrence Handle11905830 Occurrence Handle1:CAS:528:DC%2BD38XmtVSjs70%3D Occurrence Handle10.1038/35105075
M. Diwan P. Elamanchili H. Lane A. Gainer J. Samuel (2003) ArticleTitleBiodegradable nanoparticle mediated antigen delivery to human cord blood derived dendritic cells for induction of primary T cell responses J. Drug Target. 11 495–507 Occurrence Handle15203918 Occurrence Handle1:CAS:528:DC%2BD2cXjt1Crs78%3D Occurrence Handle10.1080/10611860410001670026
X. Jiao R. Y. Wang Q. Qiu H. J. Alter J. W. Shih (2004) ArticleTitleEnhanced hepatitis C virus NS3 specific Th1 immune responses induced by co-delivery of protein antigen and CpG with cationic liposomes J. Gen. Virol. 85 1545–1553 Occurrence Handle15166438 Occurrence Handle1:CAS:528:DC%2BD2cXltlGhtro%3D Occurrence Handle10.1099/vir.0.79896-0
M. Kerkmann C. L. Costa C. Richter S. Rothenfusser J. Battiany V. Hornung J. Johnson S. Englert T. Ketterer W. Heckl S. Thalhammer S. Endres G. Hartmann (2005) ArticleTitleSpontaneous formation of nucleic acid-based nanoparticles is responsible for high interferon-alpha induction by CpG-A in plasmacytoid dendritic cells J. Biol. Chem. 280 8086–8093 Occurrence Handle15591070 Occurrence Handle1:CAS:528:DC%2BD2MXhs1yitbg%3D Occurrence Handle10.1074/jbc.M410868200
S. Manoj L. A. Babiuk V. Drunen Littel-van den Hurk Particlevan (2004) ArticleTitleApproaches to enhance the efficacy of DNA vaccines Crit. Rev. Clin. Lab. Sci. 41 1–39 Occurrence Handle15077722 Occurrence Handle1:CAS:528:DC%2BD2cXivVCjs7k%3D Occurrence Handle10.1080/10408360490269251
Z. Cui R. J. Mumper (2002) ArticleTitleGenetic immunization using nanoparticles engineered from microemulsion precursor Pharm. Res. 19 939–946 Occurrence Handle12180545 Occurrence Handle1:CAS:528:DC%2BD38Xltl2is7c%3D Occurrence Handle10.1023/A:1016402019380
H. Q. Mao K. Roy V. L. Troung-La K. A. Janes K. Y. Lin Y. Wang J. T. August K. W. Leong (2001) ArticleTitleChitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency J. Control. Release 70 399–421 Occurrence Handle11182210 Occurrence Handle1:CAS:528:DC%2BD3MXhtV2murs%3D Occurrence Handle10.1016/S0168-3659(00)00361-8
M. Bivas-Benita T. H. Ottenhoff H. E. Junginger G. Borchard (2005) ArticleTitlePulmonary DNA vaccination: concepts, possibilities and perspectives J. Control. Release 107 1–29 Occurrence Handle16054263 Occurrence Handle1:CAS:528:DC%2BD2MXpvVSgu7g%3D Occurrence Handle10.1016/j.jconrel.2005.05.028
C. P. Locher D. Putnam R. Langer S. A. Witt B. M. Ashlock J. A. Levy (2003) ArticleTitleEnhancement of a human immunodeficiency virus env DNA vaccine using a novel polycationic nanoparticle formulation Immunol. Lett. 90 67–70 Occurrence Handle14687705 Occurrence Handle1:CAS:528:DC%2BD3sXpvVWqu7c%3D Occurrence Handle10.1016/j.imlet.2003.02.001
Z. Cui S. J. Han D. Padinjarae Vangasseri L. Huang (2005) ArticleTitleImmunostimulation mechanism of LPD nanoparticle as a vaccine carrier Mol. Pharmacol. 2 IssueID(1) 22–28 Occurrence Handle1:CAS:528:DC%2BD2cXhtVOjt7vN
B. Verrier (2005) ArticleTitleTherapeutic vaccination for chronic infectious diseases: lessons from HIV-1 J. Clin. Virol. 34 S9–S12 Occurrence Handle16461232 Occurrence Handle1:CAS:528:DC%2BD28XhtlGmsr0%3D Occurrence Handle10.1016/S1386-6532(05)80003-4
M. L. Michel M. Mancini-Bourgine (2005) ArticleTitleTherapeutic vaccination against chronic hepatitis B virus infection J. Clin. Virol. 34 S108–S114 Occurrence Handle16461209 Occurrence Handle1:CAS:528:DC%2BD28XhtlGnuro%3D Occurrence Handle10.1016/S1386-6532(05)80019-8
World Health Organisation. Diabetes, http://www.who.int/mediacentre/factsheets/fs138/en/index.html, (accessed Nov 15, 2005) part of http://www.who.int (accessed Nov 15, 2005).
S. I. Tanaka T. Yamakawa I. Aoki K. Okuda C. Mobbs (2004) ArticleTitleDaily nasal inoculation with the insulin gene ameliorates diabetes in mice Diabetes Res. Clin. Pract. 63 1–9 Occurrence Handle14693407 Occurrence Handle1:CAS:528:DC%2BD3sXpvF2msbw%3D Occurrence Handle10.1016/j.diabres.2003.07.005
F. Gomez-Perez J. A. Rull (2005) ArticleTitleInsulin therapy: current alternatives Arch. Med. Res. 36 258–72 Occurrence Handle15925016 Occurrence Handle1:CAS:528:DC%2BD2MXks1Cnurg%3D Occurrence Handle10.1016/j.arcmed.2005.03.012
M. Muno-Torres G. Alonso M. P. Raya (2004) ArticleTitleCalcitonin therapy in osteoporosis Treat. Endocrinol. 3 117–132 Occurrence Handle10.2165/00024677-200403020-00006
C. Prego M. Garcia D. Torres M. J. Alonso (2005) ArticleTitleTransmucosal macromolecular drug delivery J. Control. Release 101 151–162 Occurrence Handle15588901 Occurrence Handle1:CAS:528:DC%2BD2cXhtVKgu7bJ Occurrence Handle10.1016/j.jconrel.2004.07.030
Y. Cao L. Lam (2002) ArticleTitleProjections for insulin treatment for diabetics Drugs Today 38 419–427 Occurrence Handle1:CAS:528:DC%2BD38XlvVKnurs%3D Occurrence Handle10.1358/dot.2002.38.6.678349 Occurrence Handle12532178
M. Saffran B. Pansky G. Colin Budd F. E Williams (1997) ArticleTitleInsulin and the gastrointestinal tract J. Control. Release 46 89–98 Occurrence Handle1:CAS:528:DyaK2sXhtlyhsLo%3D Occurrence Handle10.1016/S0168-3659(96)01578-7
G. Dapergolas G. Gregoriadis (1976) ArticleTitleHypoglycemic effect of liposome-entrapped insulin administered intragastrically into rats Lancet 2 824–827 Occurrence Handle61498 Occurrence Handle1:CAS:528:DyaE2sXkvV0%3D Occurrence Handle10.1016/S0140-6736(76)91209-5
H. M. Patel B. E. Ryman (1976) ArticleTitleOral administration if insulin by encapsulation in liposomes FEBS Lett. 62 60–63 Occurrence Handle129340 Occurrence Handle1:CAS:528:DyaE28XhtlSks74%3D Occurrence Handle10.1016/0014-5793(76)80016-6
J. F. Woodley (1985) ArticleTitleLiposomes for oral administration of drugs Crit. Rev. Ther. Drug Carr. Syst. 2 1–18 Occurrence Handle1:CAS:528:DyaL28XhtFGqsrw%3D
C. Damgé C. Michel M. Aprahamian P. Couvreur (1988) ArticleTitleNew approach for oral administration of insulin with polyalkylcyanoacrylate nanocapsules as drug carrier Diabetes 37 246–251 Occurrence Handle3292320
R. S. Spangler (1990) ArticleTitleInsulin administration via liposomes Diabetes Care 13 911–922 Occurrence Handle2226109 Occurrence Handle1:STN:280:DyaK3M%2FjtV2jtA%3D%3D
G. P. Carino E. Mathiowitz (1999) ArticleTitleOral insulin delivery Adv. Drug Deliv. Rev. 35 249–257 Occurrence Handle10837700 Occurrence Handle1:CAS:528:DyaK1MXksFehuw%3D%3D Occurrence Handle10.1016/S0169-409X(98)00075-1
C. Vauthier M. Seiller C. Weingarten P. Couvreur (1999) ArticleTitleContribution to the development of oral dosage form for insulin delivery STP Pharm. Sci. 9 391–396 Occurrence Handle1:CAS:528:DC%2BD3cXjsFyqug%3D%3D
M. A. Kisel L. N. Kulik I. S. Tsybovsky A. P. Vlasov M. S. Vorob'yov E. A. Kholodava Z. V. Zabarovskaca (2001) ArticleTitleLiposomes with phosphatidylethanol as a carrier for oral delivery of insulin: studies in the rat Int. J. Pharm. 216 105–114 Occurrence Handle11274812 Occurrence Handle1:CAS:528:DC%2BD3MXitFyru7k%3D Occurrence Handle10.1016/S0378-5173(01)00579-8
P. Couvreur G. Barratt E. Fattal P. Legrand C. Vauthier (2002) ArticleTitleNanocapsule technology: a review Crit. Rev. Ther. Drug Carr. Syst. 19 99–134 Occurrence Handle1:CAS:528:DC%2BD38XntFSksbg%3D Occurrence Handle10.1615/CritRevTherDrugCarrierSyst.v19.i2.10
S. Watnasirichaikul T. Rades I. G. Tucker N. W. Davies (2002) ArticleTitleIn-vitro release and oral bioactivity of insulin in diabetic rats using nanocapsules dispersed in biocompatible microemulsion J. Pharm. Pharmacol. 54 473–480 Occurrence Handle11999123 Occurrence Handle1:CAS:528:DC%2BD38XjtlWgur8%3D Occurrence Handle10.1211/0022357021778736
K. Katayama Y. Kato H. Onishi T. Nagai Y. Machida (2003) ArticleTitleDouble liposomes: hypoglycemic effects of liposomal insulin on normal rats Drug Dev. Ind. Pharm. 29 725–731 Occurrence Handle12906329 Occurrence Handle1:CAS:528:DC%2BD3sXltlGmtbw%3D Occurrence Handle10.1081/DDC-120021771
N. Csaba L. Gonzalez A. Sanchez M. J. Alonso (2004) ArticleTitleDesign and characterisation of new nanoparticulate polymer blends for drug delivery J. Biomater. Sci. Polym. Ed. 15 1137–1151 Occurrence Handle15503631 Occurrence Handle1:CAS:528:DC%2BD2cXptFahurw%3D Occurrence Handle10.1163/1568562041753098
M. Simon M. Wittmar T. Kissel T. Linn (2005) ArticleTitleInsulin containing nanocomplexes formed by self-assembly from biodegradable amine-modified poly(vinyl alcohol)-graft-poly(l-lactide): bioavailability and nasal tolerability in rats Pharm. Res. 22 1879–1886 Occurrence Handle16132341 Occurrence Handle1:CAS:528:DC%2BD2MXhtFChs7bM Occurrence Handle10.1007/s11095-005-7676-z
S. Mao O. Germerhaus D. Fischer T. Linn R. Schnepf T. Kissel (2005) ArticleTitleUptake and transport of PEG-graft-trimethyl-chitosan copolymer–insulin nanocomplexes by epithelias cells Pharm. Res. 22 2058–2068 Occurrence Handle16170693 Occurrence Handle1:CAS:528:DC%2BD2MXhtlemtbnM Occurrence Handle10.1007/s11095-005-8175-y
M. Garcia-Fuentes D. Torres M. J. Alonso (2005) ArticleTitleNew surface modified lipid nanoparticles as delivery vehicle for salmon calcitonin Int. J. Pharm. 296 122–132 Occurrence Handle15885464 Occurrence Handle1:CAS:528:DC%2BD2MXktVais74%3D Occurrence Handle10.1016/j.ijpharm.2004.12.030
N. Zhang Q. N. Ping G. H. Huang W. F. Xu (2005) ArticleTitleInvestigation of lectin-modified insulin liposomes as carriers for oral administration Int. J. Pharm. 294 247–259 Occurrence Handle15814248 Occurrence Handle1:CAS:528:DC%2BD2MXjt1agsrs%3D Occurrence Handle10.1016/j.ijpharm.2005.01.018
M. Aprahamian C. Michel W. Humbert J. P. Devissaguet C. Damgé (1987) ArticleTitleTransmucosal passage of poly(alkylcyanoacrylate) nanocapsules as a new drug carrier in the small intestine Biol. Cell 61 69–76 Occurrence Handle2833966 Occurrence Handle1:CAS:528:DyaL1cXhsFKgtL0%3D
H. Pinto-Alphandary M. Aboubakar D. Jaillard P. Couvreur C. Vauthier (2003) ArticleTitleVisualization of insulin-loaded nanocapsules: in vitro and in vivo studies after oral administration to rats Pharm. Res. 20 1071–1084 Occurrence Handle12880294 Occurrence Handle1:CAS:528:DC%2BD3sXkvFSksr4%3D Occurrence Handle10.1023/A:1024470508758
A. T. Florence (2004) ArticleTitleIssues in oral nanoparticle drug carrier uptake and targeting J. Drug Target. 12 65–70 Occurrence Handle15203899 Occurrence Handle1:CAS:528:DC%2BD2cXktVCqtbo%3D Occurrence Handle10.1080/10611860410001693706
P. Couvreur V. Lenaerts B. Kante M. Roland P. Speiser (1980) ArticleTitleOral and parenteral administration of insulin associated to hydrolysable nanoparticles Acta Pharm. Technol. 26 220
C. Damgé H. Vranckx P. Balschmidt P. Couvreur (1997) ArticleTitlePoly(alkyl cyanoacrylate) nanospheres for oral administration of insulin J. Pharm. Sci. 86 1403–1409 Occurrence Handle9423155 Occurrence Handle10.1021/js970124i
M. S. Mesiha M. B. Sidhom B. Fasipe (2005) ArticleTitleOral and subcutaneous absorption of insulin poly(isobutylcyanoacrylate) nanoparticles Int. J. Pharm. 288 289–293 Occurrence Handle15620869 Occurrence Handle1:CAS:528:DC%2BD2cXhtFGhurvO Occurrence Handle10.1016/j.ijpharm.2004.10.003
C. Damgé D. Hillaire-buys R. Puech A. Hilozel C. Michel G. Ribes (1995) ArticleTitleEffect of orally administered insulin nanocapsules in normal and diabetic rats Diab. Nutr. Metab. 8 3–9
P. J. Lowe C. S. Temple (1994) ArticleTitleCalcitonin and insulin in isobutylcyanoacrylate nanocapsules: protection against proteases and effect on intestinal absorption in rats J. Pharm. Pharmacol. 46 547–552 Occurrence Handle7996380 Occurrence Handle1:CAS:528:DyaK2cXlsVWntLs%3D
M. Aboubakar P. Couvreur H. Pinto-Alphandary B. Gouritin B. Lacour R. Farinotti F. Puisieux C. Vauthier (2000) ArticleTitleInsulin-loaded nanocapsules for oral administration; in vitro and in vivo investigation Drug Dev. Res. 49 109–117 Occurrence Handle1:CAS:528:DC%2BD3cXislKis7g%3D Occurrence Handle10.1002/(SICI)1098-2299(200002)49:2<109::AID-DDR4>3.0.CO;2-#
F. Cournarie D. Auchère D. Chevenne B. Lacour M. Seiller C. Vauthier (2002) ArticleTitleAbsorption and efficiency of insulin after oral administration of insulin-loaded nanocapsules in diabetic rats Int. J. Pharm. 242 325–328 Occurrence Handle12176272 Occurrence Handle1:CAS:528:DC%2BD38Xmt1ynsb8%3D Occurrence Handle10.1016/S0378-5173(02)00175-8
G. P. Carino J. S. Jacob E. Mathiowitz (2000) ArticleTitleNanosphere based oral insulin delivery J. Control. Release 65 261–269 Occurrence Handle10699286 Occurrence Handle1:CAS:528:DC%2BD3cXhtl2qsL0%3D Occurrence Handle10.1016/S0168-3659(99)00247-3
S. Sakuma M. Hayashi M. Akashi (2001) ArticleTitleDesign of nanoparticles composed of graft copolymers for oral peptide delivery Adv. Drug Deliv. Rev. 47 21–37 Occurrence Handle11251243 Occurrence Handle1:CAS:528:DC%2BD3MXhvVajsro%3D Occurrence Handle10.1016/S0169-409X(00)00119-8
C. O. Sullivan C. Birkinshaw (2004) ArticleTitleIn vitro degradation of insulin-loaded poly(n-butylcyanoacrylate) nanoparticles Biomaterials 25 4375–4382 Occurrence Handle15046928 Occurrence Handle1:CAS:528:DC%2BD2cXitlWqt7w%3D Occurrence Handle10.1016/j.biomaterials.2003.11.001
A. Vila A. Sanchez M. Tobio P. Calvo M. J. Alonso (2002) ArticleTitleDesign of biodegradable particles for protein delivery J. Control. Release 78 15–24 Occurrence Handle11772445 Occurrence Handle1:CAS:528:DC%2BD3MXptlaisb8%3D Occurrence Handle10.1016/S0168-3659(01)00486-2
A. M. Hillery P. U. Jani A. T. Florence (1994) ArticleTitleComparative, quantitative study of lymphoid and non-lymphoid uptake of 60 nm polystyrene particles J. Drug Target. 2 151–156 Occurrence Handle8069593 Occurrence Handle1:STN:280:DyaK2czkvVygsg%3D%3D
E. Mathiowitz J. S. Jacob Y. S. Jong G. P. Carino D. E. Chickering P. Chaturvedi C. A. Santos K. Vijayaraghavan S. Montgomery S. Bassett C. Morrell (1997) ArticleTitleBiologically erodable microspheres as potential oral drug delivery systems Nature 386 410–414 Occurrence Handle9121559 Occurrence Handle1:CAS:528:DyaK2sXit1Wrt7s%3D Occurrence Handle10.1038/386410a0
F. Delie (1998) ArticleTitleEvaluation of nano- and microparticle uptake by the gastrointestinal tract Adv. Drug Deliv. Rev. 34 221–233 Occurrence Handle10837679 Occurrence Handle1:CAS:528:DyaK1cXnsFWlt7w%3D Occurrence Handle10.1016/S0169-409X(98)00041-6
L. Behrens A. I. Pena ParticleVila M. J. Alonso T. Kissel (2002) ArticleTitleComparative uptake studies of bioadhesive and non bioadhesive nanoparticles in human intestinal cell lines and rats: the effect of mucus on particle adsorption and transport Pharm. Res. 19 1185–1193 Occurrence Handle12240945 Occurrence Handle1:CAS:528:DC%2BD38XmtlGgs7g%3D Occurrence Handle10.1023/A:1019854327540
Z. Degim N. Unal D. Essiz U. Abbasoglu (2004) ArticleTitleThe effect of various liposome formulations on insulin penetration across Caco-2 cell monolayer Life Sci. 75 2819–2827 Occurrence Handle15464833 Occurrence Handle1:CAS:528:DC%2BD2cXotFCmur4%3D Occurrence Handle10.1016/j.lfs.2004.05.027
G. Ponchel J. Irache (1998) ArticleTitleSpecific and non-specific bioadhesive particulate systems for oral delivery to the gastrointestinal tract Adv. Drug Deliv. Rev. 34 191–219 Occurrence Handle10837678 Occurrence Handle1:CAS:528:DyaK1cXnsFWlt78%3D Occurrence Handle10.1016/S0169-409X(98)00040-4
S. P. Clissold A. Fitton P. Chrisp (1991) ArticleTitleIntranasal salmon calcitonin. A review of its pharmacological properties and potential utility in metabolic bone disorders associated with aging Drugs Aging 1 405–423 Occurrence Handle1794028 Occurrence Handle1:STN:280:DyaK387ntlCmsg%3D%3D
S. Turker E. Onur Y. Ozer (2004) ArticleTitleNasal route and drug delivery systems Pharm. World Sci. 26 137–142 Occurrence Handle15230360 Occurrence Handle10.1023/B:PHAR.0000026823.82950.ff
R. Fernandez-Urrusuno P. Calvo C. Rumunan-Lopez J. L. Vila-Lato M. J. Alonso (1999) ArticleTitleEnhancement of nasal absorption of insulin using chitosan nanoparticles Pharm. Res. 16 1576–1581 Occurrence Handle10554100 Occurrence Handle1:CAS:528:DyaK1MXntVOhur4%3D Occurrence Handle10.1023/A:1018908705446
A. Vila H. Gill O. McCallion M. J. Alonso (2004) ArticleTitleTransport of PLA-PEG particles across the nasal mucosa: effect of particle size and PEG coating density J. Control. Release 98 231–244 Occurrence Handle15262415 Occurrence Handle1:CAS:528:DC%2BD2cXlslGis7Y%3D Occurrence Handle10.1016/j.jconrel.2004.04.026
M. Simon M. Wittmar T. Kissel T. Linn (2005) ArticleTitleInsulin containing nanocomplexes formed by self-assembly from biodegradable amine-modified poly(vinyl alcohol)-graft-poly(l-lactide): bioavailability and nasal tolerability in rats Pharm. Res. 22 1879–1886 Occurrence Handle16132341 Occurrence Handle1:CAS:528:DC%2BD2MXhtFChs7bM Occurrence Handle10.1007/s11095-005-7676-z
C. Vermehren, S. Frokjaer, T. Aurstad, and J. Hansen. Lung surfactant as a drug delivery system. Int. J. Pharm. 307:89–92 (2006).
Y. Li A. K. Mitra (1996) ArticleTitleEffects of phospholipid chain length, concentration, charge and vesicle size on pulmonary insulin absorption Pharm. Res. 13 76–79 Occurrence Handle8668683 Occurrence Handle1:CAS:528:DyaK28XhtFajsr8%3D Occurrence Handle10.1023/A:1016029317299
J. Blanchard J. Coleman C. D'Abreu Hayling R. Ghaderi B. Haeberlin J. Hart S. Jensen R. Malcolmson S. Mittelman L. M. Nagao S. Sekulic C. Snodgrass-Pilla M. Sundahl G. Thompson R. Wolff (2004) ArticleTitleForeign particles testing in orally inhaled and nasal drug products Pharm. Res. 21 2137–2147 Occurrence Handle15648243 Occurrence Handle1:CAS:528:DC%2BD2MXjslOqsg%3D%3D Occurrence Handle10.1007/s11095-004-7665-7
G. L. Wilson E. H. Leiter (1990) ArticleTitleStreptozotocin interactions with pancreatic beta cells and the induction of insulin-dependent diabetes Curr. Top. Microbiol. Immunol. 156 27–54 Occurrence Handle2143132 Occurrence Handle1:STN:280:DyaK3czjs1eqtQ%3D%3D
O. Blondel B. Portha (1989) ArticleTitleEarly appearance of in vivo insulin resistance in adult streptozotocin-injected rats Diab. Metab. 15 382–387 Occurrence Handle1:CAS:528:DyaK3MXkt1Oh
J. P. Mordes R. Cortell E. P. Clanjenhorn A. A. Rossini D. L. Greiner (2004) ArticleTitleRat models of type 1 diabetes: genetics, environment, and autoimmunity ILAR J. 45 278–291 Occurrence Handle15229375 Occurrence Handle1:CAS:528:DC%2BD2cXkvVyjsro%3D
N. Ubrich C. Schmidt R. Bodmeier M. Hoffman P. Maincent (2005) ArticleTitleOral evaluation in rabbits of cyclosporin-loaded Eudragit RS and RL nanoparticles Int. J. Pharm. 2888 168–175
J. K. Milani U. Pleyer A. Dukes H. J. Chou S. Lutz D. Ruckert K. H. Schmidt B. J. Mondino (1993) ArticleTitleProlongation of corneal allograft survival with liposome-encapsulated cyclosporin in the rat eye Ophthalmology 100 890–896 Occurrence Handle8510902 Occurrence Handle1:STN:280:DyaK3s3ovVeltA%3D%3D
A. M. Campos ParticleDe A. Sanchez M. J. Alonso (2001) ArticleTitleChitosan nanoparticles: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin A Int. J. Pharm. 224 159–168 Occurrence Handle11472825 Occurrence Handle10.1016/S0378-5173(01)00760-8
F. Lallemand O. Felt-Baeyens K. Bessenghir F. Behar-Cohen R. Gurny (2003) ArticleTitleCyclosporin A delivery to the eye: a pharmaceutical challenge Eur. J. Pharm. Biopharm. 56 307–318 Occurrence Handle14602172 Occurrence Handle1:CAS:528:DC%2BD3sXos12qtb0%3D Occurrence Handle10.1016/S0939-6411(03)00138-3
M. G. Qaddoumi H. Ueda J. Yang J. Dvada V. Labhasetwar V. H. Lee (2004) ArticleTitleThe characteristics and mechanisms of uptake of PLGA nanoparticles in rabbit conjunctival epithelial cell layers Pharm. Res. 21 641–648 Occurrence Handle15139521 Occurrence Handle1:CAS:528:DC%2BD2cXjsVWqs7s%3D Occurrence Handle10.1023/B:PHAM.0000022411.47059.76
M. Schwartz (2001) ArticleTitleHarnessing the immune system for neuroprotection: therapeutic vaccines for acute and chronic neurodegenerative disorders Cell Mol. Neurobiol. 21 617–627 Occurrence Handle12043837 Occurrence Handle1:CAS:528:DC%2BD38XkslSktL4%3D Occurrence Handle10.1023/A:1015139718466
J. Schmidt J. M. Metselaar M. H. Wauben K. V. Toyka G. Storm R. Gold (2003) ArticleTitleDrug targeting by long-circulating liposomal glucocorticosteroids increases therapeutic efficacy in a model of multiple sclerosis Brain 126 1895–1904 Occurrence Handle12805101 Occurrence Handle10.1093/brain/awg176
Y. Kozac ParticleDe K. Andrieux H. Villarroya C. Klein B. Thillaye-Goldenberg M. C. Naud E. Garcia P. Couvreur (2004) ArticleTitleIntraocular injection of tamoxifen-loaded nanoparticles: a new treatment of experimental autoimmune uveoretinitis Eur. J. Immunol. 34 3702–3712 Occurrence Handle10.1002/eji.200425022 Occurrence Handle1:CAS:528:DC%2BD2cXhtFajtrvE
M. Schwartz (2004) ArticleTitleVaccination for glaucoma: dream or reality? Brain Res. Bull. 62 481–484 Occurrence Handle15036561 Occurrence Handle1:CAS:528:DC%2BD2cXhsVOlu7o%3D Occurrence Handle10.1016/S0361-9230(03)00073-X
C. Billotey C. Aspord O. Beuf E. Piaggio F. Gazeau M. F. Janier C. Thivolet (2005) ArticleTitleT-cell homing to the pancreas in autoimmune mouse models of diabetes: in vivo MR imaging Radiology 236 579–587 Occurrence Handle15972338
C. Vauthier E. Fattal D. Labarre (2004) From polymer chemistry and physicochemistry to nanoparticulate drug carrier design and applications M. J. Yaszemski D. J. Trantolo K. U. Lewamdrowski V. Hasirci D. E. Altobelli D. L. Wise (Eds) Biomaterial Handbook—Advanced Applications of Basic Sciences and Bioengineering Marcel Dekker, Inc. New York, USA 563–598
N. Ammoury H. Fessi J. P. Devissaguet M. Dubrasquet S. Benita (1991) ArticleTitleJejunal absorption, pharmacological activity, and pharmacokinetic evaluation of indomethacin-loaded poly(d,l-lactide) and poly(isobutyl-cyanoacrylate) nanocapsules in rats Pharm. Res. 8 101–105 Occurrence Handle2014197 Occurrence Handle1:CAS:528:DyaK3MXovVGltg%3D%3D Occurrence Handle10.1023/A:1015846810474
F. Fawaz F. Bonini M. Guyot A. M. Lagueny H. Fessi J. P. Devissaguet (1993) ArticleTitleInfluence of poly(dl-lactide) nanocapsules on the biliary clearance and enterohepatic circulation of indomethacin in the rabbit Pharm. Res. 10 750–756 Occurrence Handle8321841 Occurrence Handle1:CAS:528:DyaK3sXkvVSjtLw%3D Occurrence Handle10.1023/A:1018924219540
S. S. Guterres H. Fessi G. Barratt F. Puisieux J. P. Devissaguet (1995) ArticleTitlePoly(d,l-lactide) nanocapsules containing non-steroidal anti-inflammatory drugs: gastrointestinal tolerance following intravenous and oral administration Pharm. Res. 12 1545–1547 Occurrence Handle8584497 Occurrence Handle1:CAS:528:DyaK2MXosleqsrs%3D Occurrence Handle10.1023/A:1016208125979
J. Al-Muhammed A. Y. Ozer M. T. Ercan A. A. Hincal (1996) ArticleTitleIn-vivo studies on dexamethasone sodium phosphate liposomes J. Microencapsul. 13 293–306 Occurrence Handle8860685 Occurrence Handle1:CAS:528:DyaK28XivV2htr8%3D
S. S. Guterres H. Fessi G. Barratt F. Puisieux J. P. Devissaguet (2000) ArticleTitlePoly(rac-lactide) nanocapsules containing diclofenac: protection against muscular damage in rats J. Biomater. Sci., Polym. Ed. 11 1347–1355 Occurrence Handle1:CAS:528:DC%2BD3MXitVKrs7w%3D Occurrence Handle10.1163/156856200744372
P. Calvo M. J. Alonso J. L. Vila-Jato J. R. Robinson (1996) ArticleTitleImproved ocular bioavailability of indomethacin by novel ocular drug carriers J. Pharm. Pharmacol. 48 1147–1152 Occurrence Handle8961163 Occurrence Handle1:CAS:528:DyaK28XnsFKjtbw%3D
C. Bucolo A. Maltese G. Plugisi R. Pignatello (2002) ArticleTitleEnhanced ocular anti-inflammatory activity of ibuprofen carried by an Eudragit RS100 nanoparticle suspension Ophthalmic Res. 34 319–323 Occurrence Handle12381895 Occurrence Handle1:CAS:528:DC%2BD38XnvV2rs7w%3D Occurrence Handle10.1159/000065608
B. Jiang L. Hu C. Gao J. Shen (2005) ArticleTitleIbuprofen-loaded nanoparticles prepared by a co-precipitation method and their release properties Int. J. Pharm. 304 220–230 Occurrence Handle16182477 Occurrence Handle1:CAS:528:DC%2BD2MXhtFSitLnE Occurrence Handle10.1016/j.ijpharm.2005.08.008
M. J. Heffernan N. Murthy (2005) ArticleTitlePolyketal nanoparticles: a new pH-sensitive biodegradable drug delivery vehicle Bioconjug. Chem. 16 1340–1342 Occurrence Handle16287226 Occurrence Handle1:CAS:528:DC%2BD2MXhtVKhtr7J Occurrence Handle10.1021/bc050176w
S. A. Galindo-Rodriguez F. Puel S. Briancon E. Allemann E. Doelker H. Fessi (2005) ArticleTitleComparative scale-up of three methods for producing ibuprofen-loaded nanoparticles Eur. J. Pharm. Sci. 25 357–367 Occurrence Handle15916889 Occurrence Handle1:CAS:528:DC%2BD2MXlsVCltLk%3D Occurrence Handle10.1016/j.ejps.2005.03.013
E. Merisko-Liversidge G. G. Liversidge E. R. Cooper (2003) ArticleTitleNanosizing: a formulation approach for poorly-water-soluble compounds Eur. J. Pharm. Sci. 18 113–120 Occurrence Handle12594003 Occurrence Handle1:CAS:528:DC%2BD3sXht1Kltrg%3D Occurrence Handle10.1016/S0928-0987(02)00251-8
N. Rasenak H. Hartenhauer B. W. Muller (2003) ArticleTitleMicrocrystals for dissolution rate enhancement of poorly water-soluble drugs Int. J. Pharm. 254 137–145 Occurrence Handle10.1016/S0378-5173(03)00005-X Occurrence Handle1:CAS:528:DC%2BD3sXhsFOrtb8%3D
A. Eidelman J. M. Weiss J. Lau D. B. Carr (2005) ArticleTitleTopical anaesthetics for dermal instrumentation: a systematic review of randomized, controlled trials Ann. Emerg. Med. 46 343–351 Occurrence Handle16187468 Occurrence Handle10.1016/j.annemergmed.2005.01.028
A. Taddio H. K. Soin S. Schuh G. Koren D. Scolnik (2005) ArticleTitleLiposomal lidocaine to improve procedural success rates and reduce procedural pain among children: a randomized controlled trial CMAJ 172 1691–1695 Occurrence Handle15967972
E. R. Viscusi (2004) ArticleTitleEmerging techniques in the treatment of postoperative pain Am. J. Health-Syst. Pharm. 61 IssueID (Suppl 1) S11–S14 Occurrence Handle15119756
E. R. Vuscusi G. Martin C. T. Hartrick N. Singla G. Manvelian InstitutionalAuthorNameThe EREM Study group (2005) ArticleTitleForty-eight hours of postoperative pain relief after total hip arthroplasty with a novel, extended-release epidural morphine formulation Anesthesiology 102 1014–1022 Occurrence Handle10.1097/00000542-200505000-00022
S. A. Grant (2002) ArticleTitleThe holy grail: long acting local anaesthetics and liposomes Best Pract. Res. Clin. Anaesthesiol. 16 345–352 Occurrence Handle12491562 Occurrence Handle1:CAS:528:DC%2BD38XntVygtL0%3D Occurrence Handle10.1053/bean.2002.0242
S. Mantripragada (2002) ArticleTitleA lipid based depot (DepoFoam technology) for sustained release drug delivery Prog. Lipid Res. 41 392–406 Occurrence Handle12121719 Occurrence Handle1:CAS:528:DC%2BD38Xltleku7g%3D Occurrence Handle10.1016/S0163-7827(02)00004-8
A. Lamprecht J. L. Saumet J. Roux J. P. Benoit (2004) ArticleTitleLipid nanocarriers as drug delivery system for ibuprofen in pain treatment Int. J. Pharm. 278 407–414 Occurrence Handle15196644 Occurrence Handle1:CAS:528:DC%2BD2cXkslKlsrk%3D Occurrence Handle10.1016/j.ijpharm.2004.03.018
D. Betbeder S. Sperandio J. P. Latapie J. Nadai ParticleDe A. Etienn J. M. Zajac B. Frances (2000) ArticleTitleBiovector™ nanoparticles improve antinociceptive efficacy of nasal morphine Pharm. Res. 17 743–748 Occurrence Handle10955851 Occurrence Handle1:CAS:528:DC%2BD3cXlvVCgt78%3D Occurrence Handle10.1023/A:1007594602449
A. M. Wolka J. D. Huber T. P. Davis (2003) ArticleTitlePain and the blood–brain barrier: obstacles to drug delivery Adv. Drug Deliv. Rev. 55 987–1006 Occurrence Handle12935941 Occurrence Handle1:CAS:528:DC%2BD3sXmsVKisbY%3D Occurrence Handle10.1016/S0169-409X(03)00100-5
W. M. Pardridge (1999) ArticleTitleVector-mediated drug delivery to the brain Adv. Drug Deliv. Rev. 36 299–321 Occurrence Handle10837722 Occurrence Handle1:CAS:528:DyaK1MXhvVCnsrs%3D Occurrence Handle10.1016/S0169-409X(98)00087-8
J. C. Olivier (2005) ArticleTitleDrug transport to brain with targeted nanoparticles NeuroRx 2 108–119 Occurrence Handle15717062 Occurrence Handle10.1602/neurorx.2.1.108
W. M. Pardridge (2005) ArticleTitleDrug and gene targeting to the brain via blood–brain barrier receptor-mediated transport systems Int. Congr. Ser. 1277 49–62 Occurrence Handle10.1016/j.ics.2005.02.011 Occurrence Handle1:CAS:528:DC%2BD1cXhvVOhtb0%3D
J. Kreuter (2004) ArticleTitleInfluence of the surface properties on nanoparticle-mediated transport of drugs to the brain J. Nanosci. Nanotechnol. 4 484–488 Occurrence Handle15503433 Occurrence Handle1:CAS:528:DC%2BD2cXotVegur0%3D Occurrence Handle10.1166/jnn.2003.077
M. Brandl G. Gregoriadis (1994) ArticleTitleEntrapment of haemoglobin into liposomes by the dehydration–rehydration method: vesicle characterization and in vivo behaviour Biochim. Biophys. Acta 1196 65–75 Occurrence Handle7986812 Occurrence Handle1:CAS:528:DyaK2MXisFaktLs%3D Occurrence Handle10.1016/0005-2736(94)90296-8
H. Sakai H. Y. Masada Horinouchi E. Ikeda K. Sou S. Takeoka M. Suematsu M. Takaori K. Kobayashi E. Tsuchida (2004) ArticleTitlePhysiological capacity of the reticuloendothelial system for the degradation of hemoglobin vesicles (artificial oxygen carriers) after massive intravenous doses by daily repeated infusions for 14 days J. Pharmacol. Exp. Ther. 311 874–884 Occurrence Handle15297471 Occurrence Handle1:CAS:528:DC%2BD2cXhtVKmt7fF Occurrence Handle10.1124/jpet.104.073049
M. Takaori (2005) ArticleTitleApproach to clinical trial considering medical ethics and efficacy for HbV, liposome encapsulated hemoglobin vesicle Artif. Cells Blood Substit. Immobil. Biotechnol. 33 65–73 Occurrence Handle15768566 Occurrence Handle1:CAS:528:DC%2BD2MXislOjsr0%3D
T. M. S. Chang F. D'Agnillo W. P. Yu S. Razack (2000) ArticleTitleTwo future generations of blood substitutes based on polyhemoglobin–SOD–catalase and nanoencapsulation Adv. Drug Deliv. Rev. 40 213–218 Occurrence Handle10837791 Occurrence Handle1:CAS:528:DC%2BD3cXosVahuw%3D%3D Occurrence Handle10.1016/S0169-409X(99)00051-4
A. J. Khopade S. Khopade N. K. Jain (2002) ArticleTitleDevelopment of hemoglobin aquasomes from spherical hydroxyapatite cores precipitated in the presence of half-generation poly(amidoamine) dendrimer Int. J. Pharm. 241 145–154 Occurrence Handle12086730 Occurrence Handle1:CAS:528:DC%2BD38XkslSgs7w%3D Occurrence Handle10.1016/S0378-5173(02)00235-1
C. Chauvierre M. C. Marden C. Vauthier D. Labarre P. Couvreur L. Leclerc (2004) ArticleTitleHeparin coated poly(alkylcyanoacrylate) nanoparticles coupled to hemoglobin: a new oxygen carrier Biomaterials 25 3081–3086 Occurrence Handle14967542 Occurrence Handle1:CAS:528:DC%2BD2cXhtVemtrk%3D Occurrence Handle10.1016/j.biomaterials.2003.09.097
T. M. Chang D. Powanda W. P. Yu (2003) ArticleTitleAnalysis of polyethylene–glycol–polylactide nano-dimension artificial red blood cells maintaining systemic hemoglobin levels and prevention of methemoglobin formation Artif. Cells Blood Substit. Immobil. Biotechnol. 31 231–247 Occurrence Handle12906306 Occurrence Handle1:CAS:528:DC%2BD3sXlsFKjurc%3D Occurrence Handle10.1081/BIO-120023155
H. Sakai Y. Masada H. Onuma S. Takeoka E. Tsuchida (2004) ArticleTitleReduction of methemoglobin via electron transfer from photoreduced flavin: restoration of O2-binding of concentrated hemoglobin solution coencapsulated in phospholipid vesicles Bioconjug. Chem. 15 1037–1045 Occurrence Handle15366957 Occurrence Handle1:CAS:528:DC%2BD2cXmvFChsrk%3D Occurrence Handle10.1021/bc049913z
C. Passirani G. Barratt J. P. Devissageut D. Labarre (1998) ArticleTitleLong-circulating nanoparticles bearing heparin or dextran covalently bound to poly(methyl methacrylate) Pharm. Res. 15 1046–1050 Occurrence Handle9688058 Occurrence Handle1:CAS:528:DyaK1cXkvVWgtbc%3D Occurrence Handle10.1023/A:1011930127562
T. Flynn C. Wei (2005) ArticleTitleThe pathway to commercialization for nanomedicine Nanomed. Nanotechnol., Biol. Med. 1 47–51 Occurrence Handle1:CAS:528:DC%2BD2MXlvVSru74%3D Occurrence Handle10.1016/j.nano.2004.11.010
B. Sangro (2005) ArticleTitleRefined tools for the treatment of hepatocellular carcinoma J. Hepatol. 42 629–631 Occurrence Handle15826709 Occurrence Handle10.1016/j.jhep.2005.02.006
C. H. Dubin. Drug discovery and delivery: tear down those walls. Drug Delivery Technology. 3#5 (2005). http://www.drugdeliverytech.com/cgi-bin/article.cgi?idArticle=329 (accessed 08/09/2005), part of http://www.drugdeliverytech.com (accessed 08/09/2005).
C. L. Bennett E. A. Calhoun (2004) ArticleTitlePharmacoeconomics of liposomal anthracycline therapy Semin. Oncol. 31 191–195 Occurrence Handle15717744 Occurrence Handle1:CAS:528:DC%2BD2MXhtVynsLs%3D Occurrence Handle10.1053/j.seminoncol.2004.08.008
F. J. Martin and T. Huang. Stealth liposomal technology: current therapies and future directions. Drug Delivery Technology. 3#5 (2005). http://www.drugdeliverytech.com/cgi-bin/article.cgi?idArticle=155 (accessed 08/09/2005), part of http://www.drugdeliverytech.com (accessed 08/09/2005).
http://ClinicalTrials.gov/ct/gui/action/GetStudy (accessed 12/09/2005) part of http://ClinicalTrials.gov (accessed 12/09/2005).
Z. Galanbor S. A. Marashi B. Rajbar (2005) ArticleTitleNanotechnology helps medicine: nanoscale swimmers and their future applications Med. Hypotheses 65 198–199 Occurrence Handle10.1016/j.mehy.2005.01.023
A. Cavalcanti R. A. Freitas (2005) ArticleTitleNanorobotics control design: a collective behavior approach for medicine IEEE Trans. Nanobiosci. 4 133–140 Occurrence Handle10.1109/TNB.2005.850469
T. Kubik K. Bogunia-Kubik M. Sugisaka (2005) ArticleTitleNanotechnology on duty in medical applications Curr. Pharm. Biotechnol. 6 17–33 Occurrence Handle15727553 Occurrence Handle1:CAS:528:DC%2BD2MXhsVWqtbY%3D
M. D. Burke. Drug delivery technology assessment: the eight assessment gates. Drug Delivery Technology. 3#5 (2005). http://www.drugdeliverytech.com/cgi-bin/article.cgi?idArticle=343 (accessed 08/09/2005), part of http://www.drugdeliverytech.com (accessed 08/09/2005).
B. Bastani D. Fernandez (2002) ArticleTitleIntellectual property rights in nanotechnology Thin Solid Films 420–421 472–477 Occurrence Handle10.1016/S0040-6090(02)00843-X
N. Sadrieh. FDA perspective on nanomaterial containing products. Nanobusiness Conference May 2005. http://www.fda.gov/nanotechnology/powerpoint_conversions/May05_files/handout/index.html (accessed 6 September 2005), part of http://www.fda.gov (accessed 6 September 2005).
Nanotechnologies: A Preliminary Risk Analysis on the Basis of a Workshop Organized by the Health and Consumer Protection Directorate General of the European Commission. European Community 2004. http://europa.eu.int/comm/health/ph_risk/events_risk_en.htm (accessed 22 December 2005), part of http://europa.eu.int (accessed 22 December 2005).
P. J. Borm W. Kreyling (2004) ArticleTitleToxicological hazards of inhaled nanoparticles—potential implications for drug delivery J. Nanosci. Nanotechnol. 4 521–531 Occurrence Handle15503438 Occurrence Handle1:CAS:528:DC%2BD2cXotVegurY%3D Occurrence Handle10.1166/jnn.2004.081
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Couvreur, P., Vauthier, C. Nanotechnology: Intelligent Design to Treat Complex Disease. Pharm Res 23, 1417–1450 (2006). https://doi.org/10.1007/s11095-006-0284-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11095-006-0284-8